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DISSERTATION ORGANIZATION 
This dissertation follows the new format of thesis organization in which journal 
papers are included as the main component of the dissertation. The first chapter comprises 
the general introduction and literature review detailing the previous works of others and the 
specific aims and hypotheses of my projects. Because the thesis is one complete document, 
the manuscripts have been formatted and included as chapters two, three and four. These 
manuscripts are either going to be submitted for publication or already published. The entire 
document is tied together in the last chapter discussing the results of all three manuscripts as 
they apply to the research problems detailed in the general introduction. 
LITERATURE REVIEW 
Respiratory Syncytial Virus (RSV) 
Respiratory syncytial virus (RSV) is the most important causative agent of severe 
bronchiolitis and lower respiratory tract infections worldwide. In the United States alone, 
RSV infection causes 900,000 hospitalizations and 4,500 deaths annually. All age groups are 
susceptible to RSV and seventy percent of all children are infected within their first year of 
life (28). Neonates naturally infected with RSV were reported to become reinfected as early 
as the age of two (39). Multiple reinfections of RSV are common and support the strong 
immunomodulatory ability of this virus. Immunocompromised adults and the elderly are 
severely affected by this virus with pneumonia related complications (96). The majority of 
RSV related deaths are from the neonatal and elderly age groups (86). 
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Unsolved problem 
Numerous vaccines for RSV have been developed throughout the years with little 
efficacy. In the 1960s, a formalin-inactivated human RSV (FI-HRSV) vaccine was 
developed. Children immunized with the FI-HRSV developed more severe respiratory 
infections upon secondary exposure to live RSV. The characteristics of the immune response 
induced by FI-HRSV immunization were unknown at that time. Prime-challenge models 
were then utilized in mice to examine the immune response to secondary live RSV infection 
after initial priming with different RSV vaccines. Interestingly, a CD4+ T helper cell type two 
(Th2) response was elicited upon secondary live RSV infection after priming with inactivated 
virus, F (fusion) protein or G (glycosylated) protein subunit vaccines (33, 34,40). 
Conversely, a primary live RSV infection resulted in a CD4+ T cell type one (Thl) response 
(33). Several studies in mice and infants have indicated that a Th2 response and CD4+ T 
cells are responsible for the immunopathogenesis produced by RSV infection (6, 17, 33, 73). 
To date, no RSV vaccines are available on the market for use in children and the ineffective 
immune response remains a challenge. 
RSV Strains 
Many strains of RSV exist in the world that include those that infect human, ovine, 
caprine, and bovine. Human RSV is divided into two antigenic subgroups A and B. The 
overall antigenic relatedness of the two groups is 25%, with the F protein being most 
antigenically conserved at 50% and the G protein having the least relatedness at 7% (24). 
When comparing other species-specific RSV strains, bovine RSV (BRSV) and caprine RSV 
are phylogenetically the closest related amino acid sequence to the human RSVs. These 
ruminant RSV strains as well as ovine RSV are not completely different viruses but rather 
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represent separate antigenic subgroups of the human RSV strains (22, 24). The conservation 
pattern of amino acids in the human RSV subgroups is similar to that seen in BRSV but some 
differences are observed (24). Overall, molecular cloning and field studies have 
demonstrated that human and bovine RSV are closely related, share common antigenic 
epitopes and induce similar pathogenesis (5, 70, 95). The thesis studies reported herein utilize 
a bovine strain of RSV, BRSV 375, which was isolated by Dr. Howard Lehmkuhl (57). As a 
natural respiratory pathogen in cattle, BRSV affects young calves and leads to substantial 
economic losses in the cattle industry (54, 90). Vaccines are available for BRSV, but the 
overall efficacy is questionable (83). BRSV has been used to determine the functions of the 
nonstructural proteins 1 and 2 (NS1 and NS2), which were found to cooperatively inhibit the 
interferon a and |3 (IFN a /(3) responses of infected cells (75). Preterm and neonatal lambs 
are fully susceptible to BRSV infection having similar pathogenesis and lesions as seen in 
children infected with RSV (53, 56, 64). Overall, the utilization of BRSV and ruminants for a 
natural infection model of human RSV is extremely useful due to their many similarities. 
Viral Structure and Replication 
RSV belongs to the Pneumovirus genus of the Paramyxoviridae family and is a non-
segmented negative sense, RNA virus. The ultrastructure of the virions can be pleomorphic 
having spherical (naturally occurring) or filamentous (tissue culture derived) forms and are 
usually 150-300 nm in length (20). A lipid envelope that protects the viral genome is acquired 
from the host cell membrane during budding, and glycosylated (G), fusion (F), and small 
hydrophobic (SH) proteins are embedded into the membrane as viral surface proteins (Figure 
1). Inside the virion, the F, G, and SH proteins are in contact with the matrix (M) protein, 
located beneath the lipid envelope. The viral genome is helical in shape and located inside 
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the M protein layer. The genome consists of 15,200 nucleotides that once transcribed into 
subgenomic mRNAs, encode for 11 proteins. Associated with the single-stranded RNA 
genome are the nucleocapsid (N) protein, large polymerase subunit (L) protein and the 
phosphoprotein (P). Though the L protein is the RNA polymerase, it cannot function without 
the N and P proteins (20). Located in between each gene are repeated sequences consisting of 
a polyadenylation signal, an intergenic sequence GAA, and a translational start signal for the 
adjacent gene (12). The genes that encode for the following proteins are ordered starting at 
the 3' as follows: non-structural protein 1 (NSI), NS2, nucleocapsid (N) protein, 
phosphoprotein (P), matrix (M) protein, small hydrophobic (SH) protein, glycoprotein (G), 
fusion (F) protein, M2 factors (contains M2-1 and M2-2) and large (L) polymerase protein 
(Figure 1). Transcription is initiated at the 3'of the genome where the leader sequence is 
located and the RNA-dependent RNA polymerase (L, N, P complex) initiates transcription at 
this conserved site. Once the polymerase encounters a conserved termination signal, half of 
the complex continues along the genome. The polymerase molecules that dissociate from the 
RNA genome have to translocate back to the 3' end leader sequence and begin transcription 
again (20). This start-stop mechanism of the polymerase creates a gradient of mRNAs 
produced where the proximal 3' genes are transcribed in greater abundance than the 5' genes, 
a process which is known as transcriptional polarity (12). Therefore, the nonstructural genes 
NS1 and NS2 are transcribed in greater quantities than the L polymerase gene at the 5' end. 
Full-length mRNA transcription serves as the template for full-length genome replication 
necessary for packaging into progeny virions. The switch in individual gene transcription to 
replication is controlled by regulatory sequences within the 5' of the genome and the 
presence of M2-1 protein which serves as a transcriptional elongator (20). After replication 
5 
of the genome from the full-length positive sense mRNA is completed, assembly of the viral 
proteins and genome occurs near the lipid bilayer of the host cell where budding releases the 
newly packaged virions. 
Cellular tropisms and viral infection 
Respiratory syncytial virus is transmitted by aerosol and direct contact with infected 
respiratory secretions leading to infection of epithelial cells within the upper respiratory tract. 
Attachment of RSV virions to host cells occurs through the binding of the G protein to 
cellular glycosaminoglycans (GAGs) that contain heparan sulfate or chondroitin sulfate (36). 
Entry into a host cell occurs through plasma membrane fusion with the F2 subunit of the 
fusion (F) protein and was found to mediate species specificity of human and bovine RSV 
infections (76). Both upper and lower respiratory tract epithelial cells are the primary site of 
RSV infection and replication which induces the production of proinflammatory mediators 
(IL-1(3, IL-6, IL-8, TNFa, IL-11) and alerts the immune system of microbial infection (50). 
Chemokines produced by infected epithelial cells also contribute to the immunomodulatory 
gradient and include regulated upon activation normal T cell expressed and secreted 
(RANTES), macrophage inflammatory proteins (MlP-la and MIP-113), macrophage-derived 
chemokine (MDP), fractalkine and interferon-inducible T cell a chemoattractant (I-TAC) 
(97). A strong chemotactic gradient is produced after RSV infection and the recruitment of 
neutrophils via IL-8 and eosinophils via RANTES to the infected airways has been observed 
(41, 80). These innate inflammatory cells are thought to contribute to the 
immunopathogenesis observed in severe RSV infections which results in epithelial cell 
necrosis, inflammation of airways, and mucus overproduction leading to obstruction of the 
airways (41, 80). 
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Lung Dendritic Cells and RSV 
Lung dendritic cells (DCs) are also recruited to the mucosal surface of the lungs after 
RSV infection. An influx of DCs is observed after primary RSV infection within murine 
lungs and nasal washes of children (7, 27). In vitro data using either human monocyte or cord 
blood derived DCs have demonstrated that these potent antigen presenting cells (APCs) are 
permissive to RSV infection (2, 35, 46). Productive replication of RSV within human 
monocyte derived DCs (MDDCs) was demonstrated by flow cytometry and increased viral 
titers within the supernatants recovered from infected MDDCs (35). Other in vitro data 
utilizing bovine MDDCs have reported infection of BRSV (Snook strain) in MDDCs but 
active replication was minimal (93). Thus, in vitro data generally support the fact that RSV 
can infect certain populations of DCs. 
Discrepancies exist when analyzing phenotypic changes of DC surface antigen 
expression depending upon which species is used for in vitro studies of RSV infection. 
Bovine MDDCs infected with BRSV (Snook strain) were shown to have no modulation of 
CD80/86, MHC class I or II expression after viral exposure (93). In contrast, human 
monocyte or cord blood derived DCs infected with RSV did exhibit increased expression of 
MHC class I and II, CD80, CD83, and CD86 (35,46). Whether differences in host species or 
RSV strains are responsible for the contradicting results observed remains to be elucidated. 
Induction of cytokine and chemokine gene transcription after RSV infection has been 
studied in human and bovine MDDCs. Human MDDCs produced IL-1(3, IL-6, IL-4, IL-10, 
IL-12p40, and TNFa proteins after RSV infection (35). In addition, production of 
prostaglandin E2 and IL-11 proteins was detected in human cord blood derived DCs infected 
with RSV (2). Bovine MDDCs were induced to transcribe large amounts of IL-6 and IL-10 
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mRNA and less IL-1(5, TNFa, IL-12p40 and IL-15 after infection with the Snook strain of 
BRSV (93). 
Assays measuring the functional abilities of DCs after RSV infection include 
fluorescent-labeled tracer uptake and allogeneic T cell proliferation. Murine lung DCs 
isolated ex vivo after RSV infection endocytosed significantly less FITC-dextran via the 
mannose receptor than DCs from mock infected mice (7). The same murine DCs were 
incubated with allogeneic T cells and stimulated more T cell proliferation than DCs isolated 
from control mice (7). Together, these studies suggested that RSV infection still induced 
maturation of the DCs. Recent data from human MDDCs reported that RSV infected DCs 
were impaired and did not stimulate allogeneic CD4+ T cell proliferation better than 
uninfected DCs (35). Depending upon the host species and cell type used, the data are 
equivocal when determining if RSV interferes with DC functions. 
Alveolar macrophages and RSV 
Alveolar macrophages (AMs) not only clear microbial pathogens from the lung 
microenvironment but also produce inflammatory and immunomodulatory mediators upon 
exposure to respiratory pathogens (94). The location of AMs within the lower respiratory 
tract microenvironment and at the mucosal surface enables RSV to interact directly with 
these APCs. The permissiveness of AMs to RSV infection was confirmed by in vivo data 
from human (68) and neonatal lamb AMs that demonstrated the presence of RSV within 
these isolated cells (Chapter 3 and 4). The majority of research using AMs and RSV has 
been in vitro assays utilizing isolated AMs from healthy humans (67), mice (82), or guinea 
pigs (18) demonstrating that AMs can be infected in vitro with RSV. Active replication of 
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the virus was demonstrated in vitro with human AMs by quantitating titers of virions released 
into the culture supernatant (67). 
Currently, two studies document the observation that not all AMs exposed to RSV in 
vitro are infected with the virus. Guinea pig AMs were separated by density gradient 
centrifugation into immature and mature AMs subsets. By immunohistochemistry, more 
immature, high density AMs were infected with RSV than mature, hypodense AMs (18). 
Another study utilizing murine AMs infected with RSV reported only a subpopulation of 
AMs staining positive for RSV via immunofluorescence, though the data is not shown (25). 
Whether differentiation states, age or genetic factors make AMs susceptible to RSV infection 
is yet to be determined. 
The profile of cytokine responses induced by AMs after in vitro RSV infection has 
been quantitated either by PGR, bioassay or ELISA. The production of inflammatory 
mediators IL-6, IL-8, TNFa and RANTES has been documented in human (4), mouse (4, 25) 
and guinea pig (48) AMs infected with RSV. The replication of virus does not appear 
necessary for cytokine gene transcription and it has been reported that heat or UV-inactivated 
RSV induce similar gene activation as live RSV within human (4) and murine AMs (82). 
Studies utilizing murine AMs infected with RSV in vitro have shown altered antimicrobial 
functions after viral infection that included decreased phagocytosis, release of reactive 
oxygen intermediates and killing of Leishmania donovani promastigotes. However, the 
induction of cytokine gene transcription still occurred and was not inhibited by viral infection 
(25). 
Large animal AMs have been studied in vitro using bovine AMs infected with BRSV 
(59, 88). In general, decreased phagocytosis was reported by BRSV infected bovine AMs. 
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One study used in vivo BRSV infection of calves, and reported variable and inconsistent 
results on the phagocytic functions of the AMs ex vivo (66). In the ovine species, AMs were 
shown to contain BRSV by immunofluorescence staining of lamb lung sections after 
infection with BRSV (89). These studies in general concentrated on the basic microbial and 
phagocytic abilities of the RSV infected AMs rather than cytokine gene induction or 
signaling effects after RSV infection. Therefore, examining AM signaling after RV infection 
has yet to be fully investigated. 
Signaling events 
Many different inflammatory and immunomodulatory mediators as well as 
extracellular receptor genes have nuclear factor- KB (NF-KB) binding sites located within 
their promoters; therefore, NF-KB activation proves to be an important signaling event in 
response to viral or bacterial infection (58). Several studies have proven NF-KB to be the 
main activator of RSV-inducible gene expression of RANTES, IL-la, IL-6 and IL-8 (8, 87). 
Human A549 pulmonary type II epithelial cells, a transformed cell line, have been 
extensively used in vitro in RSV infection studies to evaluate the activation of NF-KB 
signaling (9, 13). In general, most of the studies examining RSV induced signaling pathways 
have been performed using in vitro assays. 
Few studies examine signaling pathways in cells after in vivo infection with RSV. 
One in vivo study utilizing mouse lung homogenates demonstrated two distinct pathways in 
which NF-KB activation took place after RSV infection. The first pathway was induced early 
(1.5 hours) after RSV infection, and was viral replication independent. NF-KB was activated 
and rapidly translocated to the nucleus as shown by electromobility shift assays. The cell 
type displaying early NF-KB activation had to be close to the mucosal surface and was not an 
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epithelial cell because the target cell required active viral replication for induction of the NF-
KB pathway. To establish that NF-KB was activated within AMs, they were chemically 
depleted in vivo by apoptosis before RSV infection. Early after RSV infection, NF-KB 
translocation to the nucleus was abolished in the lung homogenates supporting the role for 
AMs having the initial NF-KB induced responses after RSV infection (38). The same study 
used Toll-like receptor 4 (TLR4) knockout mice and observed no NF-KB translocation to the 
nucleus early after RSV infection. Therefore, the initial response to RSV was determined to 
be AM and TLR4 dependent, and viral replication independent. A second wave of NF-KB 
activation was observed at 24 hours after RSV infection. By this time, nuclear translocation 
of NF-KB had occurred in lung homogenates from both TLR4 knockout and AM depleted 
mice indicating that another cell type besides AMs induced NF-KB activation during viral 
infection. The virus was actively replicating by 24 hours and it was speculated that NF-KB 
activation occurred within epithelial cells, though using whole lung homogenates limits the 
study from determining what specific cell type is involved. Taken together, RSV induces 
waves of NF-KB activation early and late in infection depending upon the cell type involved. 
In general, the signaling components and pathways of NF-KB activation have been 
studied extensively. Activation of NF-KB in the cytoplasm occurs through many different 
signaling pathways and ultimately converges in the phosphorylation of the IKK1 and IKK2 
(IKB kinase 1 and 2) complex. The IKK proteins complex with NEMO (IKBY) and 
phosphorylates the inhibitor IKBCX. IKBCX in the nonphosphorylated form prevents NF-KB 
from translocating to the nucleus. The phosphorylated IKBCX becomes polyubiquitinated and 
degraded in the 26S proteasome (49). The heterodimers of NF-KB, p65 (Rel A) and p50 (NF-
KBI), are released from the inhibitory complex and are able to translocate into the nucleus 
(58). Once in the nucleus, NF-KB binds to the cytokine promoter sequences and induces the 
transcription of many immune mediators including IL-1, IL-2, IL-4, IL-8, TNFa, and IFN-J3 
(10). RSV modulation of the proteins involved in the NF-KB pathway is being elucidated in 
vitro employing transformed epithelial cell lines or in vivo using murine lung homogenates 
(15, 37, 71). RSV was shown to activate the IKK complex in mouse lung homogenates 
shortly after RSV infection (37). The M2-1 protein of RSV, known as a transcriptional 
regulator, was shown to co-immunoprecipitate with the Rel A (p65) subunit of NF-KB after 
RSV infection of A549 epithelial cells (71). Thus far, isolated lung APCs after in vivo RSV 
infection have not been studied to determine if NF-KB activation occurs in a similar pattern 
as shown in the lung homogenates experiments. In summary, RSV has been shown to 
activate the NF-KB pathway rapidly after infection. 
Toll-like receptor 4 
Signaling through TLR4, CD 14 and MD-2 also lead to the activation and nuclear 
translocation of NF-KB. Depending upon the extracellular stimuli, cytoplasmic signaling 
from the TLR4 complex to activate NF-KB can occur via two different pathways (Figure 2). 
Either pathway originates from the cytoplasmic tail of the TLR, which contains a TIR (Toll-
IL-1 receptor) domain that all TLRs have. Adaptor protein MyD88 binds the TIR domain on 
TLR4 after ligand binding has occurred. IRAK-1 (IL-1 receptor-associated kinase) binds to 
MyD88 and this occurs through interactions between their death domains (85). IRAK-4 then 
phosphorylates IRAK-1, and the phosphorylated IRAK I binds TRAF6 (tumor necrosis 
factor receptor associated factor 6) and together they dissociate from the cytoplasmic tail of 
TLR4. IRAK-1 remains associated with the membrane and the IRAK-1/TRAF6 complex 
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binds TAK1 (TGF-|3-activated kinase 1) and TAK1 binding proteins TAB1 and TAB2. 
TRAF6 along with TAK1, TAB1 and TAB2 dissociate from IRAK-1 and ultimately activate 
the IKK complex leading to NF-KB (p65, p50) activation and nuclear translocation (85). The 
activation of NF-KB via a MyD88 independent pathway utilizes TRAM, another adaptor 
protein containing a TIR domain that binds to the TIR domain of TLR4. TRIF (TIR domain-
containing adaptor inducing IFN-|3), also known as TICAM-1, dimerizes with TRAM and 
this heterodimer activates TRAF6 (43). TRAF6 leads to the phosphorylation and activation 
of the IKK complex, phosphorylation and degradation of IKB(X, and release of p65, p50 NF-
KB complex and translocation into the nucleus. 
Several studies have described the importance of TLR4 and CD 14 signaling in 
murine host defense after in vivo human RSV infection by utilizing TLR4 knockout mice 
(38, 42, 51). Taken together, the data demonstrated a lack of NF-KB mediated responses, 
reduced clearance of RSV virions and lack of NK cell recruitment. However, two other 
studies using TLR4 knockout mice refute the importance of TLR4 in paramyxovirus or RSV 
infections (21, 91). It is important to note that one study used the paramyxovirus, Sendai 
virus, whose natural host is rodents and is structurally and functionally similar to RSV. Upon 
infection with Sendai virus in either TLR4 knockout or wild type mice, the outcome of 
infection was similar and TLR4 was not necessary for host defense (91). Taken together, the 
importance of TLR4 in the host response to RSV infection remains to be elucidated. 
Toll-like receptor 3 
Toll-like receptor 3 (TLR3) is a known receptor for double stranded RNA. Upon 
stimulation of this conserved receptor, TRIF (TICAM-1) is recruited to the cytoplasmic tail 
of TLR3, and the two proteins interact through their TIR domains (85). MyD88 independent 
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signaling through TLR3 has been shown to be dependent upon the presence of TRIF (44). 
After recruitment of TRIF to TLR3, this adaptor protein activates the IKK complex, which 
leads to the release of the p65, p50 NF-KB complex and translocation into the nucleus 
(Figure 2). TRIF also activates IRF-3 (interferon regulatory factor 3), a transcription factor 
that leads to the initial production of IFN-|3. During the course of viral replication, double 
stranded RNA molecules are produced. One crucial study demonstrated that TLR3 knockout 
mice had decreased responses to Poly IC, a synthetic double stranded RNA molecule, and 
production of inflammatory proteins was reduced (1). Recently, RSV infection of TLR3-
transfected HEK 293 cells led to a greater induction of chemokines produced compared to 
vector controls but TLR3 had no effect on viral replication within the cells (74). Production 
of CCL5 (RANTES) was found to be MyD88 independent and CXCL8 (IL-8) production 
was MyD88 dependent in HEK 293 cells. Overall, signaling through TLR3 during RSV 
infection enhances the production of certain chemokines by epithelial cells, but it still 
remains unknown what effects RSV induced TLR3 signaling has on AMs and lung DCs. 
Lung Dendritic Cells 
Lung DCs are the most potent APC within the lung microenvironment. In response to 
appropriate immune or inflammatory stimuli, lung DCs migrate from the tissues to draining 
lymph nodes where they present antigen to T and B cells. These APCs play a crucial role in 
linking the innate and adaptive immune responses. Lung DCs are a heterogeneous population 
that are distributed throughout the lung parenchyma, forming a network within the epithelial 
lining of the airways (31, 77, 78, 92). Additional populations of lung DCs are found within 
the visceral pleura (79). Rodents have been used extensively for the isolation and 
identification of lung DCs. Immune surveillance and antigen presentation are important roles 
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lung DCs perform and steady state and bacterial induced migration of these cells supports 
their importance in the lung microenvironment (52, 61, 84). Viral infections also induce lung 
DC mobilization as reported after influenza virus or RSV infection within murine lungs (7, 
55). 
Surface antigen expression 
Historically, DCs have been characterized phenotypically by defining immature and 
mature stages of differentiation. Located in tissues throughout the body, immature DCs 
express low levels of MHC class I, MHC class II, and DEC-205 and do not express co-
stimulatory molecules CD80 (B7.1) and CD86 (B7.2) while functionally they are highly 
phagocytic (45). DEC-205 (CD205) is an endocytic receptor and C-type lectin that is present 
on both immature and mature populations of DCs (29). DEC-205 expression is higher on 
DCs than macrophages or lymphocytes and is used as a DC marker. After antigen capture, 
processing and maturation, increased levels of MHC class I and II, CD80 and CD86 are 
expressed on the surface of the DCs. These activated APCs migrate to the draining lymph 
nodes, are poorly phagocytic and secrete immunomodulatory mediators. Lung DCs isolated 
from mice phenotypically express low levels of CD 14, CD80, CD86 and moderate levels of 
MHC class II (11). Studies utilizing human lung DCs have reported low expression of CD 14, 
CD80 and CD86 but high MHC class II surface antigen expression (16). Therefore, when 
comparing lung DCs to the standard phenotypic parameters for immature and mature cells, 
tissue derived lung DCs can be considered phenotypically between immature and mature 
DCs. 
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Antigen uptake 
Immature DCs are known to take up antigens via receptor-mediated endocytosis and 
macropinocytosis. Once DCs have processed antigen and matured, they are unable to take up 
more antigen and shift processes to migrate to draining lymph nodes for antigen presentation 
and T cell stimulation (45). Due to this functional shift in the abilities between immature and 
mature DCs, assays have used uptake of fluorescent-labeled tracer molecules as a functional 
measure of DC maturation. Isolated human lung DCs were reported to have efficient 
mannose receptors but had reduced uptake of tracer antigen FTTC-Dextran, when compared 
to immature MDDCs (16). Though lung DCs may exhibit a mature phenotype when assayed 
for tracer endocytosis, they display an intermediate phenotype between that of immature and 
mature DCs when surface antigen expression is analyzed. 
T cell proliferation 
The ability to stimulate naïve T cells to proliferate is a defining characteristic of DCs. 
The mixed leukocyte reaction (MLR) has been used as a measure of responder T cell 
proliferation against antigens presented by allogeneic stimulator DCs. 5,6-carboxyfluorescein 
diacetate, succinimidyl ester (CFSE) labeled allogeneic T cells have been routinely used as 
an effective way to quantify MLR assays (14). The responder T cell population is generally a 
mixture of CD8+ and CD4+ T cells, but some studies will sort out CD4+ T cells for the 
proliferation assay (35). Reported data from murine and human studies demonstrate that 
lung DCs exhibit strong abilities to stimulate allogeneic and antigen-specific T proliferation 
(11, 16, 19). In summary, isolated lung DCs are functionally able to stimulate allogeneic T 
cell proliferation and this is characteristic of mature DCs. 
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Alveolar macrophages 
Functions 
The lung microenvironment is constantly being exposed to particulate matter and 
microbial pathogens. As one of the body's first lines of defense, AMs reside within the 
surfactant layer of the alveolar sacs, exposed to the incoming exogenous air from the trachea 
and bronchi (47). Alveolar macrophages play a vital role in host defense against respiratory 
infections by utilizing their abilities to phagocytize and process antigens, and produce 
immunomodulatory mediators. The plasma membrane of AMs is very dynamic in receptor 
independent phagocytosis through membrane ruffling and folding to capture antigen and 
within 30 minutes of internalization, the entire membrane can be replaced (32). Receptor 
mediated internalization of pathogens that may or may not be opsonized occur through 
several different types of surface receptors present on AMs. Opsonization of microbes with 
IgG, IgE or IgA can result in phagocytosis mediated by binding to FcyRs, FCERS, or FcaRs, 
respectively (26, 62, 65). Complement receptors (CR) have been identified on AMs including 
CRI, CR3, and CR4 (60). Additional pattern recognition receptors such as lectin-binding 
receptors, have been identified on the surface of AMs (63). 
After internalization of the receptor bound microbial pathogen, the endosome 
translocates in the cytoplasm, fuses with a lysosome vacuole and a phagolysosome forms. 
The exogenous pathogen is enzymatically digested by lysozyme or other hydrolytic enzymes, 
and the material is either exocytosed or some antigenic peptide molecules may be loaded 
onto MHC class II molecules and expressed at the surface (30). Cytosolic infection by either 
bacteria or viruses can activate the MHC class I pathway in AMs. Proteins from infectious 
agents are degraded in the 28S proteasome and these peptides are then loaded onto MHC 
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class I molecules located in the endoplasmic reticulum with the help of accessory proteins 
(45). The presentation of antigen either by MHC class I or MHC class II will lead to the 
stimulation of the appropriate T cell response to infection. Activated AMs also produce 
reactive oxygen intermediates (hydrogen peroxide, superoxide anion, hydroxyl radical) after 
phagocytosis that are beneficial for intracellular defense and extracellular antimicrobial 
killing (23). Alveolar macrophages have several mechanisms with which to protect 
themselves and the lung environment from infectious pathogens. 
Production of cytokines 
Cytokines are potent mediators that AMs use to influence immune responses in the 
lung microenvironment. Activated AMs can produce IL-la, IL-1(3, IL-6, TNFa, and IFNa/|3. 
Exposure of AMs to bacterial LPS or viruses induces production of these proinflammatory 
cytokines (3, 25, 72). Recently, human AMs were discovered to produce IL-4 after phorbol-
12-myristate-13-acetate and calcium ionophore stimulation (69). Interestingly, AMs not only 
produce IL-4 but have IL-4 receptors on their surface and signaling through the IL-4 receptor 
in the presence of LPS downregulates the AMs ability to produce IL-1(3 and TNFa (81). 
Production of chemotactic factors such as IL-8, leukotriene B4 (LBT4), macrophage 
inflammatory protein 1 and 2 (MIP-1, 2) from stimulated AMs helps recruit granulocytes to 
the site of infection (60). Overall, the physical location and functional abilities of AMs to 
ingest and produce different types of mediators and antimicrobial molecules enable these first 
response defenders to protect the lung microenvironment. 
Specific Aims 
Respiratory syncytial virus is the most prevalent causative agent of respiratory tract 
infections and bronchiolitis worldwide. In the United States alone, RSV infection causes 
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90,000 hospitalizations and 4,500 deaths annually. To date, there are no effective vaccines 
available for RSV. In neonates, RSV proves to be problematic by inducing a nonprotective, 
ineffective immune response after primary infection and infants are commonly reinfected 
with the virus several times before the age of two. The initiation of an adaptive immune 
response to RSV either by primary infection or trial vaccines must involve the most potent 
antigen presenting cells (APCs) known as dendritic cells (DCs) and alveolar macrophages 
(AMs). Little information is available describing how RSV affects DCs and AMs after in 
vivo infection. Investigating whether RSV infection of DCs and AMs in vivo can modulate 
their function and maturation are essential. The specific aims of these studies utilized 
neonatal lambs and adult sheep, a valuable experimental species used in studies of naturally 
occurring respiratory diseases. Bovine strain 375 (BRSV) was utilized for viral inoculum. 
Both in vitro and in vivo models of RSV infection were used to characterize viral 
permissiveness, phenotypic and functional changes and cytokine responses by DCs and AMs 
after exposure to the virus. 
Specific Aim 1. Determine the phenotypic and functional characteristics of isolated ovine 
lung dendritic cells from neonatal lambs and adult sheep. 
S.A.I Hypothesis. Ovine lung dendritic cells isolated from neonates and adults will differ in 
phenotype and function. 
Currently, no information is available describing lung DCs isolated from the ovine 
species. Healthy neonatal and adult sheep were used in the following studies. Lung DCs were 
isolated by a combination of mechanical and enzymatic digestion and enriched by magnetic 
sorting, then used for ex vivo analysis. Data collected from the proposed studies of this aim 
determined the phenotype and functions of neonatal and adult DCs isolated from lung tissue. 
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Identification within lung tissue, morphology and ultrastructure were analyzed and 
expression of surface antigens quantified on lung DCs. Functional characteristics were 
measured by fluorescent labeled tracer endocytosis and allogeneic T cell stimulation. The 
following studies were used to characterize the differences between lung DCs from neonatal 
and adult sheep: 
1. Identified the location of DCs within frozen lung tissue using 
immunohistochemistry. 
2. Evaluated the ultrastructure and morphology of isolated lung DCs by 
transmission electron microscopy. 
3. Quantified the surface antigen expression by flow cytometry. 
4. Assessed phagocytic abilities by fluorescent-labeled tracer phagocytosis. 
Specific Aim 2. Determine the in vivo effect of RSV infection on neonatal lung DCs. 
S.A.2 Hypothesis. RSV modulates ovine dendritic cell function by preventing complete 
maturation. 
Recent studies have characterized in vitro derived DCs after RSV exposure, but no 
data are available on isolated lung DCs after RSV infection in a natural animal host. Neonatal 
lambs were inoculated with BRSV and lung DCs isolated after 3 and 5 days post-infection. 
Lung DCs were isolated by a combination of mechanical and enzymatic digestion and 
enriched by magnetic sorting, then used for ex vivo analysis. Data collected from the 
following studies determined the effects of RSV permissiveness and replication within lung 
DCs. The effects of viral infection on the DCs functions and responsiveness were observed. 
The following studies were utilized to elucidate the effects of RSV on isolated lung DCs: 
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1. Identified BRSV infected lung DCs within frozen lung tissue by 
immunohistochemistry. 
2. Quantified BRSV replication within isolated lung DCs using SYBR Green 
chemistry. 
3. Determined surface antigen expression using flow cytometry. 
4. Assessed phagocytic and endocytic abilities by fluorescent-labeled tracer uptake 
assays. 
5. Quantified cytokine responses using SYBR Green chemistry and ovine gene 
specific primers. 
Specific Aim 3. Determine the in vivo and in vitro effect of RSV infection on neonatal and 
adult AMs. 
S.A.3 Hypothesis. RSV modulates the innate immune response by infecting and interfering 
with neonatal AM functions. 
The in vitro permissiveness of AMs for infection with RSV has been established in 
humans and small rodents. Currently, no data is available on the in vivo and in vitro effects 
of RSV infection in AMs isolated from a neonatal large animal species. Data collected from 
the proposed studies demonstrated that AMs were infected with RSV in vivo and in vitro and 
viral modulation of AM cytokine responses occurred. For in vivo studies, both BRSV and 
human RSV strain A2 were used to determine the in vivo responsiveness of neonatal AMs 
after infection. In vitro studies were used as comparisons utilizing AMs recovered from both 
neonatal lambs and adult sheep. These studies assessed the effects of RSV infection by 
comparing AM cytokine responses subsequent to stimulation with either UV-inactivated 
BRSV, a TLR3 ligand (Poly IC) or a TLR4 ligand (LPS). The presence of IL-4 in the lung 
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microenvironment after RSV infection could have immunomodulatory effects on AMs; 
therefore, AMs were exposed to recombinant human IL-4 with or without BRSV to simulate 
in vivo cytokine conditions. Taken together, these in vivo and in vitro studies determined 
whether RSV is modulating AM cytokine responses. The studies that were utilized are as 
follows: 
1. Quantified in vivo AM cytokine responses using SYBR Green chemistry with 
ovine gene specific primers. 
2. Identified ovine AM permissiveness to BRSV infection in vitro by 
immunohistochemsitry. 
3. Assessed and quantified BRSV replication in vitro via SYBR Green chemistry. 
4. Quantified cytokine responses after in vitro treatments of BRSV, BRSV with IL-
4, IL-4 only, LPS, Poly IC, UV-BRSV or control media using SYBR Green 
chemistry with ovine gene specific primers. 
References 
1. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition 
of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 
413:732-8. 
2. Bartz, H., F. Buning-Pfaue, O. Turkel, and U. Schauer. 2002. Respiratory 
syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen 
presenting cells. Clin Exp Immunol 129:438-45. 
3. Becker, S., R. B. Devlin, and J. S. Haskill. 1989. Differential production of tumor 
necrosis factor, macrophage colony stimulating factor, and interleukin 1 by human 
alveolar macrophages. J Leukoc Biol 45:353-61. 
4. Becker, S., J. Quay, and J. Soukup. 1991. Cytokine (tumor necrosis factor, IL-6, 
and IL-8) production by respiratory syncytial virus-infected human alveolar 
macrophages. J Immunol 147:4307-12. 
5. Belknap, E. B., D. K. Ciszewski, and J. C. Baker. 1995. Experimental respiratory 
syncytial virus infection in calves and lambs. J Vet Diagn Invest 7:285-98. 
6. Bendelja, K., A. Gagro, A. Bace, R. Lokar-Kolbas, V. Krsulovic-Hresic, V. 
Drazenovic, G. Mlinaric-Galinovic, and S. Rabatic. 2000. Predominant type-2 
22 
response in infants with respiratory syncytial virus (RSV) infection demonstrated by 
cytokine flow cytometry. Clin Exp Immunol 121:332-8. 
7. Beyer, M., H. Bartz, K. Horner, S. Doths, C. Koerner-Rettberg, and J. 
Schwarze. 2004. Sustained increases in numbers of pulmonary dendritic cells after 
respiratory syncytial virus infection. J Allergy Clin Immunol 113:127-33. 
8. Bitko, V., A. Velazquez, L. Yang, Y. C. Yang, and S. Barik. 1997. Transcriptional 
induction of multiple cytokines by human respiratory syncytial virus requires 
activation of NF-kappa B and is inhibited by sodium salicylate and aspirin. Virology 
232:369-78. 
9. Brasier, A. R., M. Jamaluddin, A. Casola, W. Duan, Q. Shen, and R. P. 
Garofalo. 1998. A promoter recruitment mechanism for tumor necrosis factor-alpha-
induced interleukin-8 transcription in type II pulmonary epithelial cells. Dependence 
on nuclear abundance of Rel A, NF-kappaBl, and c-Rel transcription factors. J Biol 
Chem 273:3551-61. 
10. Caamano, J., and C. A. Hunter. 2002. NF-kappaB family of transcription factors: 
central regulators of innate and adaptive immune functions. Clin Microbiol Rev 
15:414-29. 
11. Calder, C. J., J. Liversidge, and A. D. Dick. 2004. Murine respiratory tract 
dendritic cells: isolation, phenotyping and functional studies. J Immunol Methods 
287:67-77. 
12. Cann, A. 2001. Principles of molecular virology, 3rd ed. Academic Press, San Diego. 
13. Casola, A., R. P. Garofalo, H. Haeberle, T. F. Elliott, R. Lin, M. Jamaluddin, 
and A. R. Brasier. 2001. Multiple cis regulatory elements control RANTES 
promoter activity in alveolar epithelial cells infected with respiratory syncytial virus. 
J Virol 75:6428-39. 
14. Chen, J. C., M. L. Chang, and M. O. Muench. 2003. A kinetic study of the murine 
mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester 
labeling. J Immunol Methods 279:123-33. 
15. Choudhary, S., S. Boldogh, R. Garofalo, M. Jamaluddin, and A. R. Brasier. 
2005. Respiratory syncytial virus influences NF-kappaB-dependent gene expression 
through a novel pathway involving MAP3K14/NIK expression and nuclear complex 
formation with NF-kappaB2. J Virol 79:8948-59. 
16. Cochand, L., P. Isler, F. Songeon, and L. P. Nicod. 1999. Human lung dendritic 
cells have an immature phenotype with efficient mannose receptors. Am J Respir Cell 
Mol Biol 21:547-54. 
17. Connors, M., A. B. Kulkarni, C. Y. Firestone, K. L. Holmes, H. C. Morse, 3rd, A. 
V. Sotnikov, and B. R. Murphy. 1992. Pulmonary histopathology induced by 
respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized 
BALB/c mice is abrogated by depletion of CD4+ T cells. J Virol 66:7444-51. 
18. Dakhama, A., P. M. Kaan, and R. G. Hegele. 1998. Permissiveness of guinea pig 
alveolar macrophage subpopulations to acute respiratory syncytial virus infection in 
vitro. Chest 114:1681-8. 
19. Demedts, I. K., G. G. Brusselle, K. Y. Vermaelen, and R. A. Pauwels. 2005. 
Identification and characterization of human pulmonary dendritic cells. Am J Respir 
Cell Mol Biol 32:177-84. 
23 
20. Easton, A. J., J. B. Domachowske, and H. F. Rosenberg. 2004. Animal 
pneumoviruses: molecular genetics and pathogenesis. Clin Microbiol Rev 17:390-
412. 
21. Ehl, S., R. Bischoff, T. Ostler, S. Vallbracht, J. Schulte-Monting, A. Poltorak, 
and M. Freudenberg. 2004. The role of Toll-like receptor 4 versus interleukin-12 in 
immunity to respiratory syncytial virus. Eur J Immunol 34:1146-53. 
22. Elvander, M., S. Vilcek, C. Baule, A. Uttenthal, A. Ballagi-Pordany, and S. 
Belak. 1998. Genetic and antigenic analysis of the G attachment protein of bovine 
respiratory syncytial virus strains. J Gen Virol 79 (Pt 12):2939-46. 
23. Fantone, J. C., and P. A. Ward. 1982. Role of oxygen-derived free radicals and 
metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 107:395-
418. 
24. Fields, B. N., D. M. Knipe, and P. M. Howley. 1996. Fields virology, 3rd ed. 
Lippincott-Raven Publishers, Philadelphia. 
25. Franke-Ullmann, G., C. Pfortner, P. Walter, C. Steinmuller, M. L. Lohmann-
Matthes, L. Kobzik, and J. Freihorst. 1995. Alteration of pulmonary macrophage 
function by respiratory syncytial virus infection in vitro. J Immunol 154:268-80. 
26. Gauldie, J., C. Richards, and L. Lamontagne. 1983. Fc receptors for IgA and other 
immunoglobulins on resident and activated alveolar macrophages. Mol Immunol 
20:1029-37. 
27. Gill, M. A., A. K. Palucka, T. Barton, F. Ghaffar, H. Jafri, J. Banchereau, and 
O. Ramilo. 2005. Mobilization of plasmacytoid and myeloid dendritic cells to 
mucosal sites in children with respiratory syncytial virus and other viral respiratory 
infections. J Infect Dis 191:1105-15. 
28. Glezen, W. P., L. H. Taber, A. L. Frank, and J. A. Kasel. 1986. Risk of primary 
infection and reinfection with respiratory syncytial virus. Am J Dis Child 140:543-6. 
29. Gliddon, D. R., J. C. Hope, G. P. Brooke, and C. J. Howard. 2004. DEC-205 
expression on migrating dendritic cells in afferent lymph. Immunology 111:262-72. 
30. Goldsby, R. A., T. J. Kindt, J. Kuby, and B. A. Osborne. 2000. Kuby 
immunology, 4th ed. W.H. Freeman, New York. 
31. Gong, J. L., K. M. McCarthy, J. Telford, T. Tamatani, M. Miyasaka, and E. E. 
Schneeberger. 1992. Intraepithelial airway dendritic cells: a distinct subset of 
pulmonary dendritic cells obtained by microdissection. J Exp Med 175:797-807. 
32. Gordon, S. B., and R. C. Read. 2002. Macrophage defences against respiratory tract 
infections. Br Med Bull 61:45-61. 
33. Graham, B. S., G. S. Henderson, Y. W. Tang, X. Lu, K. M. Neuzil, and D. G. 
Colley. 1993. Priming immunization determines T helper cytokine mRNA expression 
patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 
151:2032-40. 
34. Graham, B. S., T. R. Johnson, and R. S. Peebles. 2000. Immune-mediated disease 
pathogenesis in respiratory syncytial virus infection. Immunopharmacology 48:237-
47. 
35. Guerrero-Plata, A., A. Casola, G. Suarez, X. Yu, L. Spetch, M. E. Peeples, and 
R. P. Garofalo. 2006. Differential response of dendritic cells to human 
24 
metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol 34:320-
9. 
36. Hacking, D., and J. Hull. 2002. Respiratory syncytial virus-viral biology and the 
host response. J Infect 45:18-24. 
37. Haeberle, H. A., A. Casola, Z. Gatalica, S. Petronella, H. J. Dieterich, P. B. 
Ernst, A. R. Brasier, and R. P. Garofalo. 2004. IkappaB kinase is a critical 
regulator of chemokine expression and lung inflammation in respiratory syncytial 
virus infection. J Virol 78:2232-41. 
38. Haeberle, H. A., R. Takizawa, A. Casola, A. R. Brasier, H. J. Dieterich, N. Van 
Rooijen, Z. Gatalica, and R. P. Garofalo. 2002. Respiratory syncytial virus-induced 
activation of nuclear factor-kappaB in the lung involves alveolar macrophages and 
toll-like receptor 4-dependent pathways. J Infect Dis 186:1199-206. 
39. Hall, C. B. 1999. Respiratory syncytial virus: A continuing culprit and conundrum. J 
Pediatr 135:2-7. 
40. Hancock, G. E., P. W. Tebbey, C. A. Scheuer, K. S. Pryharski, K. M. Heers, and 
N. A. LaPierre. 2003. Immune responses to the nonglycosylated ectodomain of 
respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia 
in inbred strains of mice with different MHC haplotypes. J Med Virol 70:301-8. 
41. Harrison, A. M., C. A. Bonville, H. F. Rosenberg, and J. B. Domachowske. 1999. 
Respiratory syncytical virus-induced chemokine expression in the lower airways: 
eosinophil recruitment and degranulation. Am J Respir Crit Care Med 159:1918-24. 
42. Haynes, L. M., D. D. Moore, E. A. Kurt-Jones, R. W. Finberg, L. J. Anderson, 
and R. A. Tripp. 2001. Involvement of toll-like receptor 4 in innate immunity to 
respiratory syncytial virus. J Virol 75:10730-7. 
43. Hoebe, K., and B. Beutler. 2004. LPS, dsRNA and the interferon bridge to adaptive 
immune responses: Trif, Tram, and other TIR adaptor proteins. J Endotoxin Res 
10:130-6. 
44. Hoebe, K., X. Du, P. Georgel, E. Janssen, K. Tabeta, S. O. Kim, J. Goode, P. Lin, 
N. Mann, S. Mudd, K. Crozat, S. Sovath, J. Han, and B. Beutler. 2003. 
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. 
Nature 424:743-8. 
45. Janeway, C. 2005. Immunobiology: the immune system in health and disease, 6th ed. 
Garland Science, New York. 
46. Jones, A., I. Morton, L. Hobson, G. S. Evans, and M. L. Everard. 2006. 
Differentiation and immune function of human dendritic cells following infection by 
respiratory syncytial virus. Clin Exp Immunol 143:513-22. 
47. Jonsson, S., D. M. Musher, A. Goree, and E. C. Lawrence. 1986. Human alveolar 
lining material and antibacterial defenses. Am Rev Respir Dis 133:136-40. 
48. Kaan, P. M., and R. G. Hegele. 2003. Interaction between respiratory syncytial virus 
and particulate matter in guinea pig alveolar macrophages. Am J Respir Cell Mol Biol 
28:697-704. 
49. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the 
control of NF-[kappa]B activity. Annu Rev Immunol 18:621-63. 
50. Krishnan, S., M. Halonen, and R. C. Welliver. 2004. Innate immune responses in 
respiratory syncytial virus infections. Viral Immunol 17:220-33. 
25 
51. Kurt-Jones, E. A., L. Popova, L. Kwinn, L. M. Haynes, L. P. Jones, R. A. Tripp, 
E. E. Walsh, M. W. Freeman, D. T. Golenbock, L. J. Anderson, and R. W. 
Finberg. 2000. Pattern recognition receptors TLR4 and CD 14 mediate response to 
respiratory syncytial virus. Nat Immunol 1:398-401. 
52. Lagranderie, M., M. A. Nahori, A. M. Balazuc, H. Kiefer-Biasizzo, J. R. Lapa e 
Silva, G. Milon, G. Marchai, and B. B. Vargaftig. 2003. Dendritic cells recruited to 
the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the 
primary immune response towards a type 1 cytokine production. Immunology 
108:352-64. 
53. Lapin, C. D., P. W. Hiatt, C. Langston, E. Mason, and P. T. Piedra. 1993. A lamb 
model for human respiratory syncytial virus infection. Pediatr Pulmonol 15:151-6. 
54. Larsen, L. E. 2000. Bovine respiratory syncytial virus (BRSV): a review. Acta Vet 
Scand 41:1-24. 
55. Legge, K. L., and T. J. Braciale. 2003. Accelerated migration of respiratory 
dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary 
infection. Immunity 18:265-77. 
56. Lehmkuhl, H. D., and R. C. Cutlip. 1979. Experimentally induced respiratory 
syncytial viral infection in lambs. Am J Vet Res 40:512-44. 
57. Lehmkuhl, H. D., P. M. Gough, and D. E. Reed. 1979. Characterization and 
identification of a bovine respiratory syncytial virus isolated from young calves. Am J 
Vet Res 40:124-6. 
58. Li, Q., and I. M. Verma. 2002. NF-kappaB regulation in the immune system. Nat 
Rev Immunol 2:725-34. 
59. Liu, L., H. D. Lehmkuhl, and M. L. Kaeberle. 1999. Synergistic effects of bovine 
respiratory syncytial virus and non-cytopathic bovine viral diarrhea virus infection on 
selected bovine alveolar macrophage functions. Can J Vet Res 63:41-8. 
60. Lohmann-Matthes, M. L., C. Steinmuller, and G. Franke-Ullmann. 1994. 
Pulmonary macrophages. Eur Respir J 7:1678-89. 
61. McWilliam, A. S., S. Napoli, A. M. Marsh, F. L. Pemper, D. J. Nelson, C. L. 
Pimm, P. A. Stumbles, T. N. Wells, and P. G. Holt. 1996. Dendritic cells are 
recruited into the airway epithelium during the inflammatory response to a broad 
spectrum of stimuli. J Exp Med 184:2429-32. 
62. Melewicz, F. M., L. E. Kline, A. B. Cohen, and H. L. Spiegelberg. 1982. 
Characterization of Fc receptors for IgE on human alveolar macrophages. Clin Exp 
Immunol 49:364-70. 
63. Meyer, K. C., C. Powers, N. Rosenthal, and R. Auerbach. 1993. Alveolar 
macrophage surface carbohydrate expression is altered in interstitial lung disease as 
determined by lectin-binding profiles. Am Rev Respir Dis 148:1325-34. 
64. Meyerholz, D. K., B. Grubor, S. J. Fach, R. E. Sacco, H. D. Lehmkuhl, J. M. 
Gallup, and M. R. Ackermann. 2004. Reduced clearance of respiratory syncytial 
virus infection in a preterm lamb model. Microbes Infect 6:1312-9. 
65. Naegel, G. P., K. R. Young, Jr., and H. Y. Reynolds. 1984. Receptors for human 
IgG subclasses on human alveolar macrophages. Am Rev Respir Dis 129:413-8. 
26 
66. Olchowy, T. W., T. R. Ames, and T. W. Molitor. 1994. Interaction of bovine 
respiratory syncytial virus with bovine alveolar macrophages in vivo: effects of virus 
infection upon selected cell functions. Can J Vet Res 58:42-8. 
67. Panuska, J. R., N. M. Cirino, F. Midulla, J. E. Despot, E. R. McFadden, Jr., and 
Y. T. Huang. 1990. Productive infection of isolated human alveolar macrophages by 
respiratory syncytial virus. J Clin Invest 86:113-9. 
68. Panuska, J. R., M. I. Hertz, H. Taraf, A. Villani, and N. M. Cirino. 1992. 
Respiratory syncytial virus infection of alveolar macrophages in adult transplant 
patients. Am Rev Respir Dis 145:934-9. 
69. Pouliot, P., V. Turmel, E. Gelinas, M. La violette, and E. Y. Bissonnette. 2005. 
Interleukin-4 production by human alveolar macrophages. Clin Exp Allergy 35:804-
10. 
70. Pringle, C. R. 1996. Virus taxonomy 1996 - a bulletin from the Xth International 
Congress of Virology in Jerusalem. Arch Virol 141:2251-6. 
71. Reimers, K., K. Buchholz, and H. Werchau. 2005. Respiratory syncytial virus M2-
1 protein induces the activation of nuclear factor kappa B. Virology 331:260-8. 
72. Roberts, N. J., Jr., A. H. Prill, and T. N. Mann. 1986. Interleukin 1 and interleukin 
1 inhibitor production by human macrophages exposed to influenza virus or 
respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor 
activity. J Exp Med 163:511-9. 
73. Roman, M., W. J. Calhoun, K. L. Hinton, L. F. Avendano, V. Simon, A. M. 
Escobar, A. Gaggero, and P. V. Diaz. 1997. Respiratory syncytial virus infection in 
infants is associated with predominant Th-2-like response. Am J Respir Crit Care 
Med 156:190-5. 
74. Rudd, B. D., E. Burstein, C. S. Duckett, X. Li, and N. W. Lukacs. 2005. 
Differential role for TLR3 in respiratory syncytial virus-induced chemokine 
expression. J Virol 79:3350-7. 
75. Schlender, J., B. Bossert, U. Buchholz, and K. K. Conzelmann. 2000. Bovine 
respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively 
antagonize alpha/beta interferon-induced antiviral response. J Virol 74:8234-42. 
76. Schlender, J., G. Zimmer, G. Herrler, and K. K. Conzelmann. 2003. Respiratory 
syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines 
the specificity of RSV infection. J Virol 77:4609-16. 
77. Schon-Hegrad, M. A., J. Oliver, P. G. McMenamin, and P. G. Holt. 1991. Studies 
on the density, distribution, and surface phenotype of intraepithelial class II major 
histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the 
conducting airways. J Exp Med 173:1345-56. 
78. Serti, K., T. Takemura, E. Tschachler, V. J. Ferrans, M. A. Kaliner, and E. M. 
Shevach. 1986. Dendritic cells with antigen-presenting capability reside in airway 
epithelium, lung parenchyma, and visceral pleura. J Exp Med 163:436-51. 
79. Simecka, J. W., J. K. Davis, and G. H. Cassell. 1986. Distribution of la antigens 
and T lymphocyte subpopulations in rat lungs. Immunology 57:93-8. 
80. Smith, P. K., S. Z. Wang, K. D. Dowling, and K. D. Forsyth. 2001. Leucocyte 
populations in respiratory syncytial virus-induced bronchiolitis. J Paediatr Child 
Health 37:146-51. 
27 
81. Sone, S., H. Yanagawa, Y. Nishioka, E. Orino, G. Bhaskaran, A. Nii, K. Mizuno, 
Y. Heike, F. Ogushi, and T. Ogura. 1992. Interleukin-4 as a potent down-regulator 
for human alveolar macrophages capable of producing tumour necrosis factor-alpha 
and interleukin-1. Eur Respir J 5:174-81. 
82. Stadnyk, A. W., T. L. Gillan, and R. Anderson. 1997. Respiratory syncytial virus 
triggers synthesis of IL-6 in BALB/c mouse alveolar macrophages in the absence of 
virus replication. Cell Immunol 176:122-6. 
83. Stott, E. J., L. H. Thomas, G. Taylor, A. P. Collins, J. Jebbett, and S. Crouch. 
1984. A comparison of three vaccines against respiratory syncytial virus in calves. J 
Hyg (Lond) 93:251-61. 
84. Stumbles, P. A., J. W. Upham, and P. G. Holt. 2003. Airway dendritic cells: co­
ordinators of immunological homeostasis and immunity in the respiratory tract. 
Apmis 111:741-55. 
85. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin Immunol 16:3-9. 
86. Thompson, W. W., D. K. Shay, E. Weintraub, L. Brammer, N. Cox, L. J. 
Anderson, and K. Fukuda. 2003. Mortality associated with influenza and 
respiratory syncytial virus in the United States. Jama 289:179-86. 
87. Tian, B., Y. Zhang, B. A. Luxon, R. P. Garofalo, A. Casola, M. Sinha, and A. R. 
Brasier. 2002. Identification of NF-kappaB-dependent gene networks in respiratory 
syncytial virus-infected cells. J Virol 76:6800-14. 
88. Trigo, E., H. D. Liggitt, J. F. Evermann, R. G. Breeze, L. Y. Huston, and R. 
Silflow. 1985. Effect of in vitro inoculation of bovine respiratory syncytial virus on 
bovine pulmonary alveolar macrophage function. Am J Vet Res 46:1098-103. 
89. Trigo, F. J., R. G. Breeze, H. D. Liggitt, J. F. Evermann, and E. Trigo. 1984. 
Interaction of bovine respiratory syncytial virus and Pasteurella haemolytica in the 
ovine lung. Am J Vet Res 45:1671-8. 
90. Van der Poel, W. H., A. Brand, J. A. Kramps, and J. T. Van Oirschot. 1994. 
Respiratory syncytial virus infections in human beings and in cattle. J Infect 29:215-
28. 
91. van der Sluijs, K. F., L. van Elden, M. Nijhuis, R. Schuurman, S. Florquin, H. 
M. Jansen, R. Lutter, and T. van der Poll. 2003. Toll-like receptor 4 is not 
involved in host defense against respiratory tract infection with Sendai virus. 
Immunol Lett 89:201-6. 
92. van Haarst, J. M., H. J. de Wit, H. A. Drexhage, and H. C. Hoogsteden. 1994. 
Distribution and immunophenotype of mononuclear phagocytes and dendritic cells in 
the human lung. Am J Respir Cell Mol Bipl 10:487-92. 
93. Werling, D., R. A. Collins, G. Taylor, and C. J. Howard. 2002. Cytokine responses 
of bovine dendritic cells and T cells following exposure to live or inactivated bovine 
respiratory syncytial virus. J Leukoc Biol 72:297-304. 
94. Wilmott, R. W., G. Khurana-Hershey, and J. M. Stark. 2000. Current concepts on 
pulmonary host defense mechanisms in children. Curr Opin Pediatr 12:187-93. 
95. Yunus, A. S., S. Krishnamurthy, M. K. Pastey, Z. Huang, S. K. Khattar, P. L. 
Collins, and S. K. Samal. 1999. Rescue of a bovine respiratory syncytial virus 
genomic RNA analog by bovine, human and ovine respiratory syncytial viruses 
28 
confirms the "functional integrity" and "cross-recognition" of BRSV cis-acting 
elements by HRSV and ORSV. Arch Virol 144:1977-90. 
96. Zambon, M. C., J. D. Stockton, J. P. Clewley, and D. M. Fleming. 2001. 
Contribution of influenza and respiratory syncytial virus to community cases of 
influenza-like illness: an observational study. Lancet 358:1410-6. 
97. Zhang, Y., B. A. Luxon, A. Casola, R. P. Garofalo, M. Jamaluddin, and A. R. 
Brasier. 2001. Expression of respiratory syncytial virus-induced chemokine gene 
networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol 
75:9044-58. 
Figure 1. Schematic diagram of Respiratory Syncytial Virus (RSV). The virion size ranges 
from 150-300 nm and contains a lipid bilayer that is acquired from the host plasma 
membrane. Virally encoded surface proteins (F, G, SH) are inserted into the plasma 
membrane when budding occurs and remain anchored by their cytoplasmic association with 
the matrix (M) protein. The RNA genome is located within the matrix protein where the N 
(nucleocapsid), P (phosphprotein), and L (large polymerase subunit) proteins are bound 
along the genome. The organization of the genome and size of virally encoded proteins 
produced are shown below the virus structure. 
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Figure 2. Schematic diagram of Toll-like receptor 3 (TLR3) and Toll-like receptor 4 (TLR4) 
signaling. Located within endosomes, TLR3 signals after binding with double stranded RNA 
that is present during viral replication. Either LPS or RSV's F protein binding the 
extracellular receptor activates toll-like receptor 4. Adaptor proteins recruited to the 
cytoplasmic tails of the TLRs lead to the activation of TRAP6 and subsequent 
phosphorylation of IKB. The NF-kB complex, p65 and p50, are released from IKB and 
translocate to the nucleus. Once in the nucleus, NF-kB binds the promoters of inflammatory 
cytokine and chemokine genes and activates their transcription. 
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CHAPTER TWO. PULMONARY DENDRITIC CELLS ISOLATED 
FROM NEONATAL AND ADULT OVINE LUNG TISSUE 
A paper published in Veterinary Immunology and Immunopathology1 
Sasha J. Fach2'3, Susan L. Brockmeier3, Lea Ann Hobbs3, Howard D. Lehmkuhl3, and 
Randy E. Sacco2,3. 
Abstract 
Lung dendritic cells (DCs) are potent antigen presenting cells (APCs) that initiate and 
modulate the adaptive immune response upon microbial infection within the pulmonary 
environment. For the first time, neonatal and adult lung DCs in a large animal model were 
compared in these studies. Here, we isolated and identified lung DCs in both neonatal and 
adult sheep, a valuable experimental animal utilized in pulmonary studies of naturally 
occurring respiratory diseases. Neonatal lung DCs exhibited characteristic dendrites and 
morphology when observed by transmission electron microscopy and expressed low to 
moderate DEC-205, CD80/86, MHC class II and CD 14. Regardless of age, lung DCs were 
functionally able to endocytose FITC conjugated ovalbumin but to a lesser degree than 
monocyte-derived DCs. In addition, neonatal lung DCs were demonstrated to be potent 
stimulators of allogeneic T cell proliferation. Together, these results demonstrate that 
neonatal and adult lung DCs are functionally similar. It is apparent from the data presented 
'Reprinted with permission of Vet Immunol Imuunopathol, 2006, April 16; Epub ahead of 
print 
2Immunobiology Graduate Program, Iowa State University, Ames, Iowa. 
3Respiratory Diseases Research Unit, National Animal Disease Center, Agricultural 
Research Services, United States Department of Agriculture, Ames, Iowa. 
that neonatal pulmonary DCs do not exhibit an intrinsic functional defect that would impair 
their ability to take up antigen and stimulate naïve T cells. These data support growing 
evidence that neonatal immune responses may differ from adults due to different 
microenvironmental influences rather than differences in dendritic cell maturation states. 
Introduction 
Dendritic cells (DCs) play a vital role in antigen capture, processing, and presentation 
to T cells. These potent antigen presenting cells (APCs) are a critical link between innate and 
adaptive immune responses. In response to the appropriate immune or inflammatory signals, 
DCs migrate from tissues to draining lymph nodes where they present antigen to T cells. DCs 
are noted for their unique dendritic morphology and ability to stimulate naive T cells that 
separate DCs from other APCs such as macrophages and B cells. These unique 
characteristics of DCs contribute to their ability to obtain and present antigen, effectively 
triggering the adaptive immune response. 
Pulmonary DCs are distributed throughout the lung parenchyma and form a network 
within the epithelium lining the airways (van Haarst et al., 1994; Schon-Hegrad et al., 1991; 
Gong et al., 1992; Serti et al., 1986). Additional lung DCs populations reside within the 
visceral pleura (Simecka et al., 1986). Rodent models have been used extensively for 
isolation and identification of lung DCs. The importance of lung DCs has been demonstrated 
in models with an increase in recruitment of DCs into the lungs after exposure to influenza 
virus or respiratory syncytial virus (RSV) infection (D'Hulst et al., 2002; Beyer et al., 2004). 
Steady state and pathogen induced migration of DCs to and from the lung demonstrates the 
active role these cells have in immune surveillance and protection (Stumbles et al., 2003; 
McWilliam et al., 1996; Lagranderie et al., 2003). 
To date, lung DCs from a large animal species have not been described. The aim of 
these studies was to compare ovine neonatal and adult lung DCs for phenotypic and 
functional differences. Monocyte-derived dendritic cells (MDDCs) have been studied and 
characterized in both bovine and ovine models but no data are available on lung DCs in these 
species (Chan et al., 2002; Howard et al., 1999; Bajer et al., 2003). The respiratory diseases 
that occur naturally in the ovine species include RSV and parainfluenza type 3 (Lindgren et 
al., 1996; Meyerholz et al., 2004; Lehmkuhl et al., 1983). Utilizing tissue derived dendritic 
cells from infected lambs will lead to valuable insights for studies on pathogen-host 
interactions. Here, we developed an isolation procedure to obtain an enriched population of 
ovine neonatal and adult lung DCs that exhibit characteristic morphology, ultrastructure and 
phenotype typical of pulmonary DCs isolated from other adult species. In addition, we show 
that neonatal and adult lung DCs are functionally similar in antigen capture and T cell 
stimulation. These results are the first reported data for isolated lung DCs in a neonatal and 
adult large animal model. 
Materials and Methods 
Animals and experimental procedure 
Two to four day old lambs (n=10) of mixed Rambouillet and Polypay breeds were 
used for neonatal lung specimens. Year old sheep (n=4) of the same mixed breeds were used 
for adult lung specimens. During necropsy, the abdominal cavity was opened and the 
abdominal aorta severed. Lungs were perfused using a similar procedure to that previously 
described for rodents (Stumbles et al., 2001). Briefly, the pulmonary artery was clamped as it 
exits the heart and catheterized with an 18-gauge needle distal to the clamp. The vasculature 
of the lungs was perfused with sterile PBS until the lungs were cleared of peripheral blood 
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and white in color. The lungs were aseptically removed, lavaged with sterile PBS to remove 
alveolar macrophages and placed in sterile PBS containing 1% antibiotic-antimycotic (Gibco, 
Carlsbad, CA). Accepted principles of animal care were followed and experiments approved 
by the NADC Animal Care and Use Committee. 
Pulmonary DC isolation and enrichment 
The entire lung was cut into small pieces using sterile scissors and forceps then digested in 
RPMI 1640 (Invitrogen, Carlsbad, CA) containing Liberase Blendzyme 3 (7 mg/ml; Roche, 
Indianapolis, IN) and DNase I, type IV from bovine pancreas (50 [xg/ml; Sigma, St. Louis, 
MO) for 1 li at 37°C. The enzymatic digestion was stopped by the addition of 10% FBS to 
the decanted supernatant and the entire digestion step was repeated on remaining tissue 
pieces. The cell suspension was filtered through sterile cheesecloth and washed with PBS. 
Contaminating RBCs were removed from cell preparations by hypotonic lysis. Cells were 
resuspended in supplemented RPMI 1640 (cRPMI) containing 10% FBS (Atlanta 
Biologicals, Lawrenceville, GA), 10% lamb serum, 2 mM L-glutamine and 1% antibiotic-
antimycotic (all from Gibco) and incubated for 12 h at 37°C in an atmosphere of 5% COz. 
Adherent and nonadherent cells were collected, pooled, washed and incubated for 10 min at 
room temperature with 10% normal goat serum (Invitrogen, Carlsbad, CA) to block 
nonspecific binding. Cells were washed and stained with monoclonal antibody BAQ153A 
(anti-ovine CD 11c; VMRD, Pullman, WA) followed by incubation with magnetic micro 
beads (Miltenyi Biotech, Auburn, CA). CDllc+ DCs (lung DCs) were obtained by twice 
positively sorting using a magnetic activated cell sorter (Miltenyi Biotech). 
Lymph node DC isolation 
Tracheobronchial and mediastinal lymph nodes were aseptically removed and placed 
in RPMI 1640. Homogenization of lymph nodes with sterile tissue grinders (Sigma) resulted 
in single cell suspensions that were incubated in cRPMI for 12 h at 37°C with 5% CO?. 
Isolation of CD1 lc+ DCs (LN DCs) was similar to that described above for pulmonary DCs. 
Peripheral blood mononuclear cell (PBMC) isolation 
Peripheral blood was collected from neonatal lambs and adult sheep into heparinized 
vacutainer tubes. Tubes were centrifuged at 480 x g for 30 min at 4°C. Buffy coats were 
harvested and contaminating RBCs removed by lysis. PBMCs were washed and resuspended 
in either RPMI or cRPMI depending upon the assay. 
Monocyte-derived macrophages and DCs 
PBMCs suspended in cRPMI were dispensed into 6 well plates (lxlO6 cells/3ml) and 
incubated overnight at 37°C with 5% CO%. The wells were washed to remove nonadherent 
cells and cRPMI supplemented with 5 ng/ml of recombinant human GM-CSF and 2 ng/ml of 
recombinant human IL-4 was added. Medium was changed every 2-3 d and cells were 
allowed to differentiate into monocyte-derived DCs (MDDCs) for 7 d. Maturation of 
MDDCs was induced by the addition of Escherichia coli LPS 055:B5 (liig/ml; Sigma) to 
culture supernatants for another 72 h. Macrophages were derived from adherent cells that 
were cultured in cRPMI and harvested on d 7. 
Transmission Electron Microscopy (TEM) 
CDllc+ cells were fixed in 2.5% gluteraldehyde in 0.1M sodium cacodylate buffer. 
Cells were post-fixed in osmium tetroxide and embedded in Eponate 12 resin. Samples were 
polymerized at 60°C for 48 h. Blocks were sectioned and stained with uranyl acetate and 
Reynolds lead citrate. Samples were viewed using a Tecnai G2 Biotwin (FBI Company, 
Hillsboro, OR) transmission electron microscope. 
Immunohistochemistry 
Samples of PB S-perfused lung were frozen in OCT medium in an ethanol and dry ice 
bath. Sections were cut onto silanated glass slides, fixed in acetone for 5 min and stored at -
80°C. Slides were rehydrated in IX Tris buffer and blocked with normal goat serum 
(Kirkegaard Perry Labs, Gaithersburg, MD) for 30 min at room temperature. The slides were 
washed in IX Tris buffer and incubated with primary antibodies diluted in IX Tris buffer, 
PBS and 3% BSA. Primary antibodies included BAQ153A (anti-ovine CDllc) and CC98 
(anti-bovine DEC-205), which were incubated at 4°C overnight. Slides were washed with IX 
Tris buffer and incubated for 30 min at 37°C with isotype specific secondary antibodies 
conjugated to Alexa Fluor 488 and Alexa Fluor 633 (Molecular Probes). To visualize nuclei, 
slides were washed and incubated with 4',6-diamidino-2-phenylindole, dilactate (DAPI, 
300nM; Molecular Probes) for 5 min at room temperature. The slides were washed with IX 
Tris buffer and cover slips mounted with a 50-50 glycerin and PBS solution. Tissue sections 
were examined using a Leica TCS-NT confocal scanning laser microscope (Leica 
Microsystems, Inc., Exton, PA). Images were prepared using Adobe Photoshop version CS 
and InDesign version 3. 
Flow cytometry 
Isolated CDllc+ cells were analyzed for cell surface antigens using three-color flow 
cytometry. Cell concentrations were adjusted to 1 x 105 cells/ml and stained using different 
combinations of primary and secondary antibodies (Abs) diluted in FACs buffer (balanced 
salt solution with 1% FBS and 0.1% sodium azide). Ovine specific monoclonal Abs obtained 
from VMRD were used for detection of CD14 (CAM36A), CDllc (BAQ153A), MHC class 
I (BC5), and MHC class II (TH14B). Cross-reactive CDllb (CC126) and DEC-205 (CC98) 
monoclonal Abs were obtained from Serotec (Raleigh, NC). CD80/86 was detected by 
human CD 152-muIg/R-PE fusion protein (Ancell, Baymont, MN). Isotype specific primary 
Abs used were anti-mouse IgGl, IgG2b, IgG2a and IgM (Serotec). Secondary Abs (Southern 
Biotechnology Associates, Birmingham, AL) included anti-IgM PE, anti-IgG2b PE, anti-
IgG2b FITC, anti-IgG2a FITC, and anti-IgM FITC. Anti-IgGl Tricolor was obtained from 
Caltag Laboratories (Burlingame, CA). Cells were washed with FACs buffer and 
resuspended in 2% paraformaldehyde in PBS. Each sample had 10,000 events collected using 
a Becton Dickinson LSR flow cytometer (San Jose, CA). Analysis of cell surface marker 
expression was done using FloJo software (Tree Star, Inc., Ashland, OR). 
Tracer Endocytosis 
FITC conjugated ovalbumin (FITC-OVA; Molecular Probes, Eugene, OR) was used 
to examine the endocytic abilities of the different DC populations. CDllc+ cell 
concentrations were adjusted to 1 x 105 cells/ml and incubated at 37°C or 4°C for one h with 
FITC-OVA (1 mg/ml). Cells were washed with FACs buffer and resuspended in 2% 
paraformaldehyde in PBS. 10,000 events were acquired for each sample using a flow 
cytometer (Becton Dickinson LSR). Data were analyzed using FloJo software (Tree Star, 
Inc.). 
T cell stimulatory capacity 
Allogeneic T cells were labeled with anti-CD4 (17D1; VMRD), magnetic micro 
beads (Miltenyi Biotech) and positively selected by magnetic activated cell sorting. T cell 
proliferation was assessed by 5,6-carboxyfluorescein diacetate, succinimidyl ester (CFSE) 
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staining (l^M/ml; Molecular Probes). CFSE, irreversibly coupled to intracellular proteins is 
equally divided between daughter cells as a result of cell division. Labeled T cells 
(2.5x105/ml) were resuspended in cRPMI and stimulated with monocyte-derived 
macrophages, MDDCs or lung DCs at varying stimulator to responder ratios (1:1, 10, 50, 
100). Co-cultures were incubated at 37°C with 5% CO2 for 3 d. Analysis of CFSE 
fluorescence intensity of T cells was performed using flow cytometry. Cells were analyzed 
using ModFit LT™ software (Verity Software House, Inc., Topsham, ME). 
Statistical analysis 
Data were expressed as the mean ± SEM. Samples were compared using an unpaired 
two-tailed Student's t test. Significance was determined by P < 0.05. 
Results 
Localization of CDllc+DEC-205+ cells within the lung parenchyma 
Previous reports have identified pulmonary DCs within the lung parenchyma of the 
upper and lower lobes (Stumbles et al., 2003). Frozen lung sections from the upper right lobe 
of neonatal lamb lungs were stained for the presence of DCs. DAPI was used to stain nuclei 
to enhance visualization of the overall cellular distribution within the tissue sections. CDllc 
and DEC-205 staining were observed on cells in alveoli near bronchioles (Figure 1). The 
majority of CD1 lc+ cells co-expressed DEC-205 and these double positive cells were 
distributed around the alveolar sacs and within the lung parenchyma. Previous reports have 
identified DEC-205 on subsets of DCs in the mouse, human and bovine species (Gliddon et 
al., 2004). 
Pulmonary DC morphology 
Unique ultrastructural characteristics of lung DCs have been used to positively 
identify these cells by either confocal or electron microscopy. In the present studies, TEM 
was utilized to examine the ultrastructure of purified CD1 lc+ lung DCs. Isolated ovine lung 
CD1 lc+ cells exhibited typical DC morphology, including long dendrites and multivacuolar 
and multilamellar vesicles (Figure 2A, B). However, these vesicles were less numerous than 
observed for MDDCs (Figure 2C). 
Analysis of surface antigen expression 
To date, large animal lung DCs have yet to be characterized and our study compares 
phenotypic data of isolated lung DCs from neonatal and adult sheep. Over ninety percent of 
all isolated CD1 lc+ lung DCs co-expressed DEC-205 (Figure 3 A, 4A). Regardless of the 
age, low to moderate expression was observed for DEC-205, CD80/86, MHC class II and 
CD14 (Figure 3B, 4B). The only notable phenotypic difference in lung DCs between 
neonates and adults was a higher MHC class I expression on neonatal cells (Figure 3B). 
When lung DCs were compared to monocyte-derived macrophages, differences were 
observed in that macrophages expressed higher CD 14 and lower DEC-205, MHC class I, and 
MHC class II (Figure 4B). Higher expression of DEC-205 and lower expression of CD 14 are 
both indicative of dendritic cells (Gliddon et al., 22004; Nicod et al., 2001). In both neonates 
and adults, immature and mature MDDCs demonstrated low expression of all surface 
molecules when compared to lung DCs except for two molecules in the adults (Tables 1 and 
2). Mature, adult MDDCs expressed higher CD80/86 and MHC class I than their lung DCs 
counterparts (Figure 4B). CD1 lc+ DCs were isolated from lymph nodes (LN DCs) of both 
adult and neonatal sheep for phenotypic comparisons of lung DCs. In general, within age 
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groups the lung and LN DC populations expressed higher levels of most surface antigens 
when compared to immature MDDCs (Tables 1 and 2). 
Endocytic capabilities 
The ability of immature DCs to take up antigen in the lung environment is crucial for 
generating an immune response to invading pathogens. Several pathways exist for antigen 
uptake and FITC-OVA was used as a measure of receptor-mediated endocytosis via clathrin-
coated pits. There was no observable difference between neonatal and adult lung DCs in their 
ability to endocytose FITC-OVA (Figure 5). FITC-OVA uptake by lung and LN DCs was 
similar between age groups. Of note was a significantly different (P<0.05) endocytosis 
observed between the MDDCs and lung DCs. The MDDCs from both age groups were able 
to endocytose more FITC-OVA than the lung or LN DCs. Consequently, lung DCs isolated 
in the present experiments cannot be considered fully mature since they are capable of 
antigen uptake albeit to a lesser degree than immature MDDCs. 
Allogeneic T cell stimulation by isolated lung DCs 
One unique characteristic of DCs is their ability to stimulate naive T cells to 
proliferate. DCs of monocyte, lung and LN origin were used at various concentrations (104, 
105, 106) to stimulate allogeneic T cells (2 x 104) labeled with CFSE (Figure 6). Control 
monocyte-derived macrophages were included as a comparative population of APCs. As 
expected, analysis of proliferation as measured by the reduction in CFSE fluorescence 
revealed weak allogeneic T cell stimulation by macrophages (72% remaining in the parent 
population). Increasing the ratio of macrophages to responder cells did not increase the T cell 
proliferative response (data not shown). MDDCs stimulated more allogeneic T cells to 
proliferate (45% remaining in the parent population) than macrophages (P<0.05). Moreover, 
lung DCs were also potent stimulators of allogeneic T cell proliferation even at a ratio of 0.5 
DC : 1 T cell (16 % T cells remaining in the parent population). Increasing the ratio of lung 
DCs to T cells by 5:1 further enhanced allogenic proliferation (4 % T cells remaining in the 
parent population). 
Discussion 
In large animal models, lung dendritic cell biology has not been well characterized. 
In order to identify lung DCs, a combination of phenotypic characterization, morphological 
criteria and functional assays were applied. CDllc mAb, BAQ153A, was chosen to sort lung 
DCs due to its ability to label a majority of afferent lymph dendritic cells and very few lung 
tissue macrophages in the ovine species (Gupta et al., 1993). Our results demonstrate the 
presence of CD1 lc+DEC205+ cells distributed throughout the lung parenchyma and airway 
epithelium, which has been confirmed in rodent models and human tissue samples (van 
Haarst et al., 1994; Schon-Hegrad et al., 1991; Gong et al., 1992; Takano et al., 2005). DEC-
205 (CD205) is a C-type lectin that functions as an endocytic receptor on DCs and is present 
on both immature and mature DC populations (Gliddon et al., 2004). Expression of DEC-205 
is higher on DCs compared to macrophages or lymphocytes. Phenotypic analysis showed that 
the isolated cell-surface characteristics were generally lower CD 14 and higher DEC-205, 
CD80/86, MHC class II as compared to monocyte-derived macrophages. Moreover, the lung 
derived cells were effective stimulators in allogenic MLRs, a hallmark feature of DCs. 
Enzymatic digestion and magnetic activated cell sorting of ovine lung tissue resulted 
in a population of DCs that exhibited characteristic morphology of dendrites, multivacuolar 
cytoplasm and typical size for DCs. Morphological differences between MDDCs and lung 
DCs were noted with the former having more vacuoles present in the cytoplasm. Processing 
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of DCs may alter their phenotype and functional properties, but our data is consistent with 
lung DCs isolated from rodents and human lung samples (Schon-Hegrad et al., 1991; Calder 
et al., 2004; Cochand et al., 1999; Gonzalez-Juarrero et al., 1999). In general, ovine lung DCs 
are phenotypically similar to their rodent counterparts and express comparable low levels of 
CD 14, CD80/86 and moderate levels of MHC class II (Calder et al., 2004). Moreover, 
studies from human lung DCs reported low expression of CD 14, CD80 and CD86 but high 
MHC class II expression (Cochand et al., 1999). Thus, as compared to MDDCs, it is evident 
that lung DCs can be considered phenotypically between immature and mature stages. Fine 
phenotypic discrimination of ovine lung DC subsets awaits further study. 
Adult and neonatal rodent and human lung samples have been utilized for the 
characterization of pulmonary DCs (Schon-Hegrad et al., 1991; McCarthy et al., 1992; 
Cadler et al., 2004; Demedts et al., 2005). To date, characterization of neonatal lung DCs in a 
large animal species have not yet been reported. We were interested in addressing the 
question of whether or not phenotypic or functional differences existed between adult and 
neonatal lung DCs due to the ongoing debate concerning the maturity of the immune 
response in neonates (Adkins et al., 2004; Goriely et al., 2001; Muthukkumar et al., 2000). 
Recently, isolated CD1 lc+ DCs from the spleens of neonatal mice were shown to be 
functionally competent in stimulating Thl responses in the adult murine microenvironment 
(Sun et al., 2005). Their data suggest that MHC class II and CD86 expression is similar on 
both neonatal and adult splenic DCs. Our observations support their findings in that lung and 
LN DCs from both neonates and adults have similar expression levels of MHC class II, 
CD80/86 and CD 14. One notable difference between the age groups was the markedly higher 
expression of MHC class I on neonatal lung DCs. At present, it is not clear why neonatal 
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lung DCs express such high levels of MHC class I. Overall, neonatal and adult ovine lung 
DCs exhibit similar phenotypic characteristics. 
Numerous studies have examined in vz'/ro-derived DCs (e.g., bone marrow or 
monocyte-derived), primarily due to the relative ease with which sufficient numbers of cells 
can be obtained. In the present experiments, MDDCs were used as a basis for comparison. In 
contrast to lung DCs, phenotypic expression of cell surface antigens on MDDCs differed 
between neonates and adults. Adult sheep MDDCs expressed higher levels of the co-
stimulatory molecule CD80/86, MHC class I and MHC class II than the neonatal MDDCs. 
Levels of expressions for these surface antigens, as well as CD 14 are in agreement with a 
previous report characterizing MDDCs from adult sheep (Chan et al., 2002). Based on our 
research and that of others (Calder et al., 2004; Cochand et al., 1999; Gonzalez-Juarrero et 
al., 2001), it is apparent that tissue derived DCs differ from their in vitro-derived 
counterparts. Whether the parameters that define immature and mature in vzYro-derived DCs 
are adequate for distinguishing maturation stages of tissue-derived DCs is not clear. 
Immature DCs are known to take up antigen via receptor-mediated endocytosis and 
macropinocytosis. As a functional measure of maturation state, ovine lung DCs from both 
neonates and adults were incubated with FITC-OVA to measure their endocytic capabilities. 
The age of the animal had no significant effect on the lung DCs' ability to take up FITC-
OVA. Statistically significant differences in the ability to endocytose the fluorescent-labeled 
tracer molecules were exhibited between lung DC and MDDC populations. Lung DCs were 
functionally more mature than MDDCs as evidenced by lower uptake via clathrin-coated 
pits. These results parallel previous studies that have reported reduced uptake of a tracer 
antigen by lung DCs when compared to immature MDDCs (Cochand et al., 1999). A 
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hallmark of a fully mature DC is their inability to uptake antigen. Based on this criterion, 
lung DCs have not attained full maturation, but rather exist in a semi-mature state. 
The ability to stimulate naïve T cells to proliferate is a defining characteristic of DCs. 
The mixed leukocyte reaction has been used as a measure of responder T cell proliferation 
against antigens presented by allogeneic stimulator DCs. Utilizing CFSE labeling of 
allogenic T cells has been demonstrated as an effective way to quantify MLR assays (Chen at 
al., 2003). As expected, ovine lung DCs exhibited this distinguishing feature of potent 
stimulators of T cell proliferation when compared to monocyte-derived macrophages. In fact, 
isolated lung DCs were the most potent of the APCs examined at stimulating allogeneic T 
cells to proliferate as measured by the percentage of daughter T cells generated during five 
days of co-culture. In contrast, monocyte-derived macrophages stimulated few allogeneic T 
cells to proliferate with the majority of these cells remaining in the parent population. These 
data are similar to other rodent and human studies that report lung DCs exhibiting strong 
abilities to stimulate allogeneic and antigen specific T proliferation (Calder et al., 2004; 
Cochand et al., 1999; Demedts et al., 2005). In summary, isolated ovine lung DCs are 
functionally able to stimulate allogeneic T cell proliferation. 
Neonates generate nonprotective immune responses to specific respiratory pathogens 
resulting in increased morbidity and mortality when compared to adults. The similarities 
described here between neonate and adult lung DCs suggest the immaturity of neonatal DCs 
cannot be the reason for the ineffective immune response. It is plausible to suggest that the 
neonatal lung microenvironment is critical to the development of an immune response that 
does not protect. The results of the present studies have important implications foi the design 
of effective vaccines for use against respiratory pathogens in neonates. 
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Table 1 
Expression of selected cell-surface molecules on neonatal ovine dendritic cell populations 
CD14 DEC-205 CD80/86 MHC I MHC II 
Immature 0.9 ±0.1 
o
 
+
i o
 
+1 00 22.3 ± 3.6 1.9 = 0.1 
MDDCs 
Mature 0.9 ±0.1 0.4 ± 0.2 -4
 
4^
 
1+
 
O
 
25.8 ±5.5 0.6 ±0 
MDDCs 
6.1 ± 1.5a'b 20.6 ± 5.7a'b Lung DCs 27.2 ± 17.1 833.3 ± 267.3'^ 18.6 ±7.1 
LN DCs 
CN +1 m
 10.3 ± 0.9° 15.0 ±2.9= 991.1 ± 131.Ie 
r
-
+
l o
 
Data are expressed in terms of mean fluorescence intensity (MFI) of the cell surface antigen 
minus the MFI of the appropriate isotype control ± SEM. The data set includes cells 
recovered from ten neonatal lambs. 
^Significantly higher compared to immature MDDCs (P<0.05). 
^Significantly higher compared to mature MDDCs (P<0.05). 
'Significantly higher compared to immature MDDCs (P<0.05). 
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Table 2 
Expression of selected cell-surface molecules on adult ovine macrophage and dendritic cell 
populations 
CD14 DEC-205 CD80/86 MHC I MHC II 
Macrophages 
Immature 
MDDCs 
Mature 
MDDCs 
Lung DCs 
LN DCs 
13.2 ±0.6 
2.1 ±0.2 
2.2 ± 0.4 
8.9 ± 4.4b'c 
5.7 ±2.6 
0.9 ± 0.2 
1.2 ±0.3 
2.5 ± 0.5 
13.5 ± 3a'c 
37.7 ± 10.3 
16.2 ±3.8 
19.5 ±6.4 
38.4 ± 8.6 
14.4 ±3.7 
17.4 ±4.3 
7.0 ± 2.4 
61.9 ±4.6 
123.1 ±44.2 
61.7 ± 1 la 
128.9 ±22.1d 
2.2 ± 0.2 
5.5 ±0.7 
6.7 ± 1.4 
36.3 ± 13.6 
62.1 ± 16.ld 
Mean fluorescence intensity (MFI) of the cell surface antigen minus the MFI of the 
appropriate isotype control ± SEM is shown. The data set includes cells recovered from 
four adult sheep. 
Significantly higher compared to monocyte-derived macrophages (P0.05). 
^Significantly higher compared to immature MDDCs (P0.05). 
'Significantly higher compared to mature MDDCs (P<0.05). 
^Significantly higher compared to immature MDDCs (P0.05). 
Figure 1. Immunofluorescence staining of dendritic cells within neonatal ovine lung 
cryosections. Sections were incubated with primary antibodies directed against CD1 lc (A) or 
DEC-205 (B) followed by secondary antibodies fluorescently labeled with Alexa Fluor 633 
(red) or Alexa Fluor 488 (green). Multi-color immunofluorescence staining shows dual 
labeled DCs (C) and nuclear staining with DAPI (blue). Co-expression of molecules is shown 
by yellow (arrows). Scale bars: A-C, 10 pim. 
Ul 
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Figure 1 
Figure 2. Transmission electron micrograph (TEM) showing morphological characteristics 
of sorted CD1 lc+ lung dendritic cells (A, B) and monocyte-derived dendritic cells (C). Cells 
were isolated by magnetic activated cell sorting and stained by standard methodology for 
TEM. Characteristic large diameter mononuclear cells with microvillus projections were 
observed. Scale bars: A-C, 2 jxm. 
Figure 2 
Figure 3. Flow cytometric analysis of surface antigen expression on neonatal ovine DC 
populations. Isolated adherent mononuclear cells were cultured for 7 d with supplemented 
medium containing recombinant human GM-CSF (5 ng/ml) and IL-4 (2 ng/ml). Samples of 
monocyte-derived dendritic cells (MDDCs; immature) were stimulated with LPS (1 ng/ml) 
for an additional 3 d to induce maturation. Magnetic sorting was used to purify CDl lc+ cells 
from digested suspensions of neonatal lungs (Lung DCs) or tracheobronchial and mediastinal 
lymph nodes (LN DCs). Over ninety percent of the neonatal lung DCs (A) co-expressed 
CDl lc and DEC-205. For the cell surface antigens examined, antigens on neonatal lung DCs 
exceeded that of cell surface antigens expressed on MDDCs (B). Shaded histograms 
represent isotype control antibodies. Number shown in the upper right corner of each plot is 
the mean fluorescence intensity (MFI) for the cell surface antigen minus the MFI of the 
isotype control. Data shown are representative of results obtained from ten neonatal lambs. 
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Figure 4. Flow cytometric analysis of surface antigen expression on adult ovine macrophage 
or DC subsets. Isolated adherent mononuclear cells were cultured for 7 d with supplemented 
medium to obtain monocyte-derived macrophages. DC populations were derived as 
described in Figure 3. The majority of adult lung DCs (A) were CDl lc and DEC-205 double 
positive. Adult lung DCs (B) expressed higher levels of DEC-205, MHC class I and MHC 
class II, but lower levels of CD 14 compared to monocyte-derived macrophages. Shaded 
histograms represent staining with isotype-matched control antibodies. Number shown in 
each panel is the mean fluorescence intensity (MFI) for staining of the indicated cell surface 
antigen minus the MFI of staining with the isotype control antibody. Data shown are 
representative of results obtained from four adult sheep. 
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Figure 5. Uptake of FITC-ovalbumin (FITC-OVA) by various DC populations. Lung, LN 
and monocyte-derived DCs were adjusted to a concentration of lxl 05 cells per ml and 
incubated with FITC-OVA for 1 h at 37°C or 4°C. Delta mean fluorescence intensities (MFI) 
shown are the values at 37°C minus the values at 4°C. Statistical analyses indicated that 
uptake of FITC-OVA by monocyte-derived DCs was significantly greater than that observed 
for lung or LN DCs (* P<0.05). Uptake of FITC-OVA did not differ between neonatal and 
adult DCs. 
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Figure 6. Allogeneic T cell stimulation by macrophages or DC populations. Isolated T cells 
were labeled with CFSE and co-cultured with neonate lung DCs (A, B), monocyte-derived 
DCs (C) or monocyte-derived macrophages (D) for 3 d. T cell proliferation was assessed by 
CFSE staining which irreversibly couples to intracellular proteins and is equally divided 
among daughter cells as a result of cell proliferation. ModFit LT analysis reveals the T cell 
parent population and daughter generations following stimulation with the various APC 
populations (A 0.5:1, B5:1,C1:1,D1:1 ratio of stimulator to responder cells). The number 
presented in the right upper hand corner of each panel is the percentage of cells remaining in 
the parent T cell population. Lung DCs were potent stimulators of allogeneic T cell 
proliferation as compared to monocyte-derived macrophages. Data shown are representative 
of four neonatal lambs. 
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CHAPTER THREE. NEONATAL OVINE PULMONARY DENDRITIC 
CELLS SUPPORT BRSV REPLICATION WITH ENHANCED IL-4 AND 
IL-10 GENE TRANSCRIPTS 
A paper to be submitted to Viral Immunology 
Sasha J. Fach1'3, David K. Meyerholz2, Jack M. Gallup2, Mark R. Ackermann2, Howard D. 
Lehmkuhl3, and Randy E. Sacco1'3. 
Abstract 
The lung microenvironment is constantly being exposed to microorganisms and 
particulate matter. Lung dendritic cells (DCs) play a crucial role in the uptake and processing 
of antigens found within the respiratory tract. Respiratory syncytial virus (RSV) is a common 
respiratory tract pathogen in children that induces an influx of DCs to the mucosal surfaces 
of the lung. Utilizing a neonatal lamb model, we examined the in vivo permissiveness of DCs 
to RSV infection, as well as overall cell surface changes and cytokine responses of isolated 
lung DCs after bovine RSV (BRSV) infection. We report that isolated lung DCs and alveolar 
macrophages support BRSV replication. Isolated lung DCs were determined to be susceptible 
to BRSV infection as demonstrated by quantification of BRSV NS2 mRNA. BRSV infection 
induced an initial up-regulation of CD 14 expression on lung DCs, but by 5 days post­
infection (PI) expression was similar to that on control cells. No significant changes in 
'immunobiology Graduate Program, Iowa State University, Ames, Iowa. 
department of Veterinary Pathology, Iowa State University, Ames, Iowa. 
3Respiratory Diseases Research Unit, National Animal Disease Center, Agricultural 
Research Services, United States Department of Agriculture, Ames, Iowa. 
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CD80/86 or MHC class I expression were seen on lung DCs after BRSV infection. Low to 
moderate expression of MHC class II and DEC-205 was detected by day 5 PI. Initially at day 
3 PI, lung DCs from BRSV-infected lambs had decreased endocytosis of FITC-OVA. The 
amount of FITC-OVA endocytosed by lung DCs isolated at day 5 PI was similar to controls. 
The most interesting observation was the induction of immunomodulatory IL-4 and IL-10 
cytokine gene transcription in lung DCs and AMs after in vivo infection with BRSV. Overall, 
these findings are the first to demonstrate that neonatal lung DCs support in vivo BRSV 
replication and produce type II cytokines after viral infection. 
Introduction 
Respiratory syncytial virus (RSV) is a prominent viral pathogen whose tropism for 
the lower respiratory tract causes severe bronchiolitis and pneumonia. Infants and young 
children are most susceptible to the virus and reinfections are common due to an ineffective 
immune response to the virus (17, 18, 42). The pathogenesis of RSV is believed to be a 
combination of host proinflammatory cytokine production and the cytopathic effects of viral 
replication (39). Lung epithelial cells are a primary site for RSV replication but data from 
studies with monocyte derived dendritic cells (MDDCs) and alveolar macrophages (AMs) 
support that in vitro replication of the virus does occur in other cell types (6, 14,21, 31). 
An influx of DCs after RSV infection has been documented within the lungs of 
infected mice and by isolation of DCs from nasal washes of RSV infected children (3,13). 
Dendritic cells are important sentinels of the immune system and play a crucial role in 
antigen capture, processing and presentation to T cells. As the most potent antigen presenting 
cells (APCs), DCs link the innate and adaptive immune responses after microbial infection. 
Upon viral infection, DCs are well equipped to prime T cells for primary and secondary 
antiviral responses. Therefore, viruses have been found to target DCs and modulate surface 
antigen expression, maturation and cytokine production (32). A prominent respiratory 
pathogen belonging to the same Paramyxoviridae family as RSV is the measles virus (MV), 
whose immunosuppression of DCs has been well documented using in vitro derived DCs 
(CD34+ precursors or monocytes) or Langerhans cells (16, 34, 35). MV modulates infected 
DCs through inhibition of maturation, IL-12 production, and CD80 and CD86 expression. In 
addition, herpes virus (22), polio virus (41), and vaccinia virus (8) have been shown to infect 
DCs and suppress their maturation, antigen presentation and cytokine production. 
To date, only in vivo adult lung DCs or in vitro derived DCs have been examined 
after RSV infection (1,3, 14, 44). Neonatal, tissue isolated lung DCs have not been examined 
ex vivo after RSV infection. In the present studies, we utilized neonatal lambs experimentally 
infected with bovine RSV (BRSV). Neonatal lambs have been utilized in pulmonary studies 
of naturally occurring respiratory diseases (25, 26, 29). The first aim of these studies was to 
isolate neonatal lung DCs after in vivo BRSV infection to determine if these cells would 
support viral replication. Secondly, lung DCs were examined to determine the effects of viral 
infection on surface antigen expression and cytokine mRNA induction. We previously 
developed a procedure for the isolation and enrichment of CDl lc+ lung DCs from neonatal 
lambs (9). In the present study, we report BRSV replication occurs within isolated lung DCs 
and AMs in vivo. Phenotypic changes due to the effects of viral infection were examined. 
Functional characteristics of lung DCs were determined by antigen uptake assays and 
cytokine gene transcription. Interestingly, BRSV induced IL-4 and IL-10 gene transcription 
in lung DCs and AMs. Results indicate that isolated lung APCs can support BRSV 
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replication and that immunomodulatory cytokines are up regulated early in infection. 
Materials and Methods 
Animals and experimental procedure 
Healthy two to four day old lambs of mixed Rambouillet and Polypay breeds were 
used for the experiments. Lambs received Naxcel (2.2 mg/kg once a day, intramuscular) to 
prevent secondary bacterial complications (40) as previously done in a premature lamb 
model (29). Lambs were bottle fed four times a day with commercial milk replacer. Lambs 
received an intratracheal inoculation of either 22 ml of BRSV 375 inoculum or sterile 
medium with a 30cc sterile syringe and 20 gauge needle. Necropsies of day three post 
inoculation (PI) lambs (n=6), day five PI lambs (n=6) or control lambs (n=6) were conducted 
using the following procedure. Lambs were euthanized with an intravenous injection of sodium 
pentobarbital. During necropsy, the abdominal cavity was opened and the abdominal aorta 
severed. Lungs were perfused using a similar procedure to that previously described (9, 37). 
Briefly, the pulmonary artery was clamped as it exits the heart and catheterized with an 18-
gauge needle distal to the clamp. The vasculature of the lungs was perfused with sterile PBS 
until the lungs were cleared of peripheral blood and pale pink in color. The lungs were 
aseptically removed, lavaged with sterile PBS to remove alveolar macrophages and placed in 
sterile PBS containing 1% antibiotic-antimycotic (Invitrogen, Carlsbad, CA). Accepted 
principles of animal care were followed and experiments approved by the NADC Animal 
Care and Use Committee. 
Viral Inoculum 
Bovine RSV (BRSV) 375 was propagated on adherent bovine turbinate ceils. By 
seven days of incubation or when over 90% of viral induced cytopathic effect was observed, 
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flasks were frozen at -80C. Within two days, the flasks were thawed and all the media 
pooled. After thorough mixing and sterile filtration, viral inoculum was aliquoted and stored 
at -80C. Standard plaque assay was used to determine the tissue culture infectious dosage 
(TCID50), 104'9 TCID50 per ml (3.97 x 104 plaque forming units (PFU/ml). The viral 
inoculum was BVDV free as tested by PCR (data not shown). 
Pulmonary DC isolation and enrichment 
The entire lung was cut into small pieces using sterile scissors and forceps then 
digested in RPMI 1640 (Invitrogen, Carlsbad, CA) containing Liberase Blendzyme 3 (7 
mg/ml; Roche, Indianapolis, IN) and DNase I, type IV from bovine pancreas (50 [xg/ml; 
Sigma, St. Louis, MO) for 1 h at 37°C. The enzymatic digestion was stopped by the addition 
of 10% FBS to the decanted supernatant and the entire digestion step was repeated on 
remaining tissue pieces. The cell suspension was filtered through sterile cheesecloth and 
washed with PBS. Contaminating RBCs were removed from cell preparations by hypotonic 
lysis. Cells were resuspended in supplemented RPMI 1640 (cRPMI) containing 10% FBS 
(Atlanta Biologicals, Lawrenceville, GA), 10% lamb serum, 2 mM L-glutamine and 1% 
antibiotic-antimycotic (all from Gibco) and incubated for 12 h at 37°C in an atmosphere of 
5% CO2. Adherent and nonadherent cells were collected, washed and incubated for 10 min at 
room temperature with 10% normal goat serum (Invitrogen, Carlsbad, CA) to block 
nonspecific binding. Cells were washed and stained with monoclonal antibody BAQ153A 
(anti-ovine CD 11c; VMRD, Pullman, WA) followed by incubation with magnetic micro 
beads (Miltenyi Biotech, Auburn, CA). CDllc+ DCs (lung DCs) were obtained by twice 
positively sorting using a magnetic activated cell sorter (Miltenyi Biotech). 
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Immunohistochemistry 
Samples of PB S-perfused lung were frozen in OCT medium in an ethanol-dry ice 
bath. Sections were cut onto silanated glass slides, fixed in acetone for 5 min and stored at 
minus 80°C. Slides were rehydrated in IX Tris buffer and blocked with normal goat serum 
(Kirkegaard Perry Labs, Gaithersburg, MD) for 30 min at room temperature. The slides were 
washed in IX Tris buffer and incubated with primary antibody BAQ153A (anti-ovine 
CD1 le; VMRD) diluted in IX Tris buffer, PBS and 3% BSA overnight at 4°C. Slides were 
rinsed and polyclonal BRSV-FITC (50 (xl; VMRD) was added for 30 min at 37°C. Slides 
were washed with IX Tris buffer and incubated for 30 min at 37°C with isotype specific 
secondary antibodies conjugated to Alexa Fluor 633 (Molecular Probes, Eugene, OR). To 
visualize nuclei, slides were washed and incubated with 4',6-diamidino-2-phenylindole, 
dilactate (DAPI, 300nM; Molecular Probes) for 5 min at room temperature. The slides were 
washed with IX Tris buffer and cover slips mounted with a 50-50 glycerin and PBS solution. 
Tissue sections were examined using a Leica TCS-NT confocal scanning laser microscope 
(Leica Microsystems, Inc., Exton, PA). Images were prepared using Adobe Photoshop 
version CS and InDesign version 3. 
Flow cytometry 
Isolated CDllc+ cells were analyzed for cell surface antigens using three-color flow 
cytometry. Cell concentrations were adjusted to 1 x 105 cells/ml and stained using different 
combinations of primary and secondary antibodies (Abs) diluted in FACs buffer (balanced 
salt solution with 1% FBS and 0.1% sodium azide). Ovine specific monoclonal Abs obtained 
from VMRD were used for detection of CD 14 (CAM36A), CD1 le (BAQ153A), MHC class 
I (BC5), and MHC class II (TH14B). Cross-reactive CDllb (CCI26) and DEC-205 (CC98) 
monoclonal Abs were obtained from Serotec (Raleigh, NC). CD80/86 was detected by 
human CD 152-muIg/R-PE fusion protein (Ancell, Baymont, MN). Isotype specific primary 
Abs used were anti-mouse IgGl, IgG2b, IgG2a and IgM (Serotec). Secondary Abs (Southern 
Biotechnology Associates, Birmingham, AL) included anti-IgM PE, anti-IgG2b PE, anti-
IgG2b FITC, anti-IgG2a FITC, and anti-IgM FITC. Anti-IgGl Tricolor was obtained from 
Caltag Laboratories (Burlingame, CA). Cells were washed with FACs buffer and 
resuspended in 2% paraformaldehyde in PBS. Each sample had 10,000 events collected using 
a Becton Dickinson LSR flow cytometer (San Jose, CA). Analysis of cell surface marker 
expression was done using FloJo software (Tree Star, Inc., Ashland, OR). 
Tracer Endocytosis 
FITC conjugated ovalbumin (FITC-OVA; Molecular Probes) and FITC conjugated 
dextran (FITC-dextran; Molecular Probes) was used to examine the endocytic abilities of the 
lung DC populations. CDllc+ cell concentrations were adjusted to 1 x 105 cells/ml and 
incubated at 37°C or 4°C for one h with FITC-OVA or FITC-dextran (1 mg/ml). Cells were 
washed with FACs buffer and resuspended in 2% paraformaldehyde in PBS. 10,000 events 
were acquired for each sample using a flow cytometer (Becton Dickinson LSR). Data were 
analyzed using FloJo software (Tree Star, Inc.). 
RNA Extraction and cDNA synthesis 
Sorted CDllc+ pulmonary cells were pelleted in sterile 1.5 ml eppendorf tubes. Cells 
were resuspended in 600 ul of RLT buffer plus 2-Mercaptoethanol from the RNeasy Mini 
RNA Isolation kit (Qiagen, Valencia, CA) and stored at -80°C. Total RNA was isolated using 
the RNeasy Mini RNA Isolation Kit (Qiagen) according to manufacturer's instructions. 
Contaminating genomic DNA was removed during RNA isolation by an on-column RNase-
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Free DNase I digestion set (Qiagen) according to manufacturer's instructions. Total RNA 
was eluted by the addition of 40 fxl of DNase-RNase free water. One pig of total RNA from 
each sample was reverse transcribed using oligo(dT)i2-ig primers (Invitrogen). 
Cytokine and BRSV NS2 mRNA quantification 
Primers were designed specifically for SYBR Green quantification using the Primer 
Select program (DNASTAR Inc., Madison, WI) with suggested parameters for SYBR Green 
chemistry that included product size no larger than 100-150 base pairs and a 50°C annealing 
temperature. Ovine ribosomal protein S15 was chosen as the endogenous control for the 
genes of interest, which are listed in Table 1. Oligo(dT) cDNA was diluted 1:10 in DNase-
RNase free water and 2 |xl used for quantification. SYBR Green PCR Master Mix (Applied 
Biosystems, Foster City, CA) was used according to manufacturer's instructions. An Applied 
Biosystems 7300 Real Time PCR Systems machine was used with the same amplification 
conditions for all genes of interest: 10 min at 95°C, 15 sec at 95°C, 40 cycles of 1 min at 
50°C, with a dissociation step of 15 sec at 95°C, 30 sec at 50°C, 15 sec at 95°C. Final relative 
quantification was calculated using the 2"aaCt method (27), where the amount of target gene 
is normalized to an endogenous control (ovine ribosomal protein S15) and expressed relative 
to control cells. Primers were validated on the Applied Biosystems 7300 machine by using 
serial dilutions of total RNA with ovine ribosomal protein S15 and target gene primers, 
whose values were plotted as the log input amount versus ACj values (target gene C% -
endogenous control CT) for relative efficiency. Only primers with a slope of less than 0.1 
were used, due to similar amplification efficiencies as the endogenous control. 
In sterile eppendorf tubes, 20 ul of total RNA from BRSV 375 inoculum and BRSV 
oligo(dT) cDNA were treated with RNase If (1 unit/jxl; New England Biolabs, Ipswich, MA) 
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or untreated and all four samples were incubated for 30 min at 37°C. The digestion of single 
stranded RNA was stopped by heating the tubes at 70°C for 20 min. Removal of the RNase 
enzyme was performed by Microcon column exclusion (100U columns; Millipore, Billerica, 
MA) according to manufacturer's instructions. Samples were quantified using BRSV NS2 
primers and SYBR Green chemistry as previously described above. No amplification of 
genomic BRSV NS2 was observed (data not shown). 
Statistical analysis 
Flow cytometric data were expressed as the mean fluorescence intensity ± SEM. 
Cytokine data was expressed as the fold change in expression relative to controls. Statistical 
analysis of the data was performed using an unpaired two-tailed Student's test. Significance 
was determined by P < 0.05. 
Results 
Co-localization of BRSV and CDllc+ DCs within lung parenchyma 
Immunofluorescent staining was utilized to demonstrate the presence of BRSV 
antigen within lung DCs. Frozen lung sections from the upper right lobe of neonatal lamb 
lungs of control, day 3 and 5 PI lambs were stained for the presence of BRSV and CD1 lc. 
DAPI was used as a nuclear stain to enhance visualization of the overall cellular distribution 
within the tissue sections. Co-expression of BRSV antigen and CDllc were seen in the 
alveolar septa and subjacent to bronchiolar epithelium (Fig. 1). No BRSV antigen staining 
was detected in control lamb lung cryosections (data not shown). Over all, analysis of the 
immunofluorescently stained frozen sections showed BRSV antigens co-localized within 
lung DCs. However, additional experiments were required to determine whether lung DCs 
support active viral replication. 
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BRSV replication within antigen presenting cells 
Upon initiation of replication, the RNA dependent RNA polymerase transcribes the 
RSV negative sense genome in the 3' to 5' direction. Large amounts of the nonstructural 
proteins NS1 and NS2 mRNA are produced during viral replication, which is a result of the 
genome's transcriptional polarity where the genes on the 3' end are transcribed in greater 
amounts than the 5' end genes (4, 10). To detect BRSV replication within lung DCs and 
AMs, primers were designed to the NS2 mRNA of BRSV and relative quantification was 
performed using SYBR Green chemistry. Expression of BRSV mRNA was detected in both 
DCs and AMs, and the NS2 transcript levels in AMs exceeded the detected levels in the lung 
DCs (Fig. 2). Taken together, these results demonstrate that both lung DCs and AMs support 
BRSV replication in vivo. 
Analysis of surface antigen expression 
Isolated lung DCs were analyzed for surface antigen expression after 3 and 5 d PI of 
BRSV. Over ninety percent of all isolated CDllc+ lung DCs co-expressed DEC-205 (Fig. 
3A). A significant increase in CD 14 expression was observed on lung DCs isolated from 3 d 
PI lambs when compared to control lung DCs (Fig. 3B). However, CD14 expression on 
isolated lung DCs 5 d PI was similar to that on control lung DCs. Expression of DEC-205, 
MHC class I and CD80/86 increased from day 3 to day 5 PI, but no significant differences 
over controls were noted (Fig. 3B). No significant changes in MHC class II expression 
during BRSV infection were observed. Overall, BRSV infection induced a notable change in 
CD 14 expression, but no significant changes in expression of surface antigens necessary for 
presentation and stimulation of antiviral T cells responses were observed. 
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Antigen uptake after BRSV exposure 
Functional characteristics of lung DCs isolated from BRSV infected lambs were 
assayed by measuring their endocytic uptake of antigens. Several pathways exist for antigen 
uptake and FITC-OVA was used as a measure of receptor-mediated endocytosis via clathrin-
coated pits. In addition, FITC-dextran uptake was used to measure mannose receptor 
mediated endocytosis by lung DCs. Endocytosis of FITC-OVA was significantly decreased 
from lung DCs isolated after d 3 PI of BRSV when compared to controls (Fig. 4). By d 5 PI, 
lung DCs endocytosed significantly more FITC-OVA than at d 3 PI (*P<0.05). Mannose 
receptor mediated endocytosis of FITC-dextran was lower in the controls and lung DCs from 
BRSV infected lambs and no significant differences were noted (Fig. 4). Therefore, lung DCs 
are still able to take up antigen after 5 d of BRSV infection. 
Lung DCs produce immunomodulatory IL-4 and IL-10 after BRSV infection 
Cytokine gene expression was quantified using SYBR Green chemistry and primers 
specific for proinflammatory and immunomodulatory genes. Less than a 2-fold increase of 
proinflammatory mediators IL-ip, TNFa, IL-6, IL-8 and IL-12p40 were detected in isolated 
lung DCs from d 3 and 5 PI lambs (Fig. 5). In addition, similar results were seen in AMs 
although IL-6 and IL-12p40 mRNA expression was higher than in lung DCs. Of note, a 
striking induction of IL-4 mRNA transcripts was detected in lung DCs at both 3 and 5 d PI. 
Moreover, a 10 to 15 fold increase in AM IL-4 mRNA transcription was observed, but this 
was lower than the levels in the lung DCs. Finally, we observed a two to four fold increase in 
IL-10 mRNA transcripts in lung DCs. Of note, no significant increases in cytokine or 
chemokine mRNA expression were observed from samples recovered from DCs or AMs at d 
3 compared to d 5 PI. Taken together, these results show that there is an early bias toward the 
production of immunomodulatory IL-4 and IL-10 gene transcripts in lung DCs and AMs 
isolated from BRSV infected lambs. 
Discussion 
In the present studies, we have utilized a neonatal lamb model for BRSV infection in 
which pathogenesis and lesions observed (bronchiolitis, inflammatory cell infiltrates, goblet 
cell hyperplasia) are similar to RSV infection in children (23, 24, 28-30). Interestingly, 
alveolar development begins prenatally in both humans and lambs, whereas mice have 
postnatal alveolar development (11). Therefore, neonatal lamb lungs are similar 
developmentally to neonatal humans and represent a comparable model for RSV infection. 
When comparing species-specific RSV strains BRSV and ovine RSV are phylogenetically 
the closest related sequence to the human RSVs. These ruminant RSV strains are not 
completely different viruses but rather represent separate antigenic subgroups of the human 
RSV strains (7, 10). The conservation pattern of amino acids in the human RSV subgroups is 
similar to that seen in BRSV but some differences are observed (10). Overall, molecular 
cloning and field studies have demonstrated that human and bovine RSV are closely related, 
share common antigenic epitopes and induce similar pathogenesis (2, 33, 45). Lambs can be 
naturally infected with BRSV and are fully susceptible to experimental BRSV infections (2). 
Taken together, lambs are an excellent model for experimental BRSV infections. 
Currently, there are no data available examining in vivo derived lung DCs after RSV 
infection in a neonatal animal model (3). The results derived from neonatal lambs in the 
present study demonstrate that BRSV antigen and CDllc co-localize on cells within the lung 
parenchyma and alveolar spaces. After 3 and 5 d PI with BRSV, isolated CD1 lc+ lung DCs 
and AMs contained NS2 mRNA transcripts, indicative of BRSV replication within these 
cells. After in vivo BRSV infection at d 3 PI, lung DCs increased CD 14 expression and 
exhibited decreased endocytosis of OVA-FITC. By d 5 PI, lung DCs expressed low to 
moderate levels of DEC-205, CD 14, and MHC class II, whereas higher expression of MHC 
class I and CD80/86 were detected. Inflammatory mediators IL-1|3, IL-6, IL-8, IL-12p40 and 
TNFa were transcribed in small amounts within lung DCs, whereas a 3.5 and 75 fold 
increase in gene transcripts of IL-10 and IL-4 were quantitated within these cells. Higher 
levels of IL-6 and IL-12p40 were transcribed in isolated AMs when compared to lung DCs. 
Overall, BRSV leads to a type II skewing of the lung DC response by inducing IL-4 and IL-
10 mRNA. The virus may inhibit the initial maturation of the lung DCs since CD80/86 and 
MHC class I expression are not increased until d 5 after infection. Overall, RSV may 
modulate lung DCs by inducing an immunomodulatory cytokine response. 
Identification and magnetic sorting of DCs was performed using CDllc mAb, 
BAQ153A, which specifically labels a majority of afferent lymph DCs and very few lung 
tissue macrophages in the ovine species (15). Our results demonstrate the co-localization of 
BRSV antigen and CDllc+ cells within frozen lung tissue sections from BRSV infected 
lambs. These results are consistent with other in vivo data that used isolated cells from nasal 
washes of infected children and reported HLA-DR positive cells co-expressing RSV fusion 
(F) protein (13). In addition to staining for viral antigen, we utilized detection of viral mRNA 
to address the question of whether or not BRSV was replicating within the lung DCs in vivo. 
After 3 and 5 d PI of BRSV, our results indicate that both lung DCs and AMs are permissive 
to BRSV infection and support replication, as quantified by the presence NS2 mRNA. These 
results are in agreement with in vitro data demonstrating that monocyte derived DCs 
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(MDDCs) can be productively infected with RSV (14). In addition, in vitro data with 
monocyte or cord blood derived DCs report these cells are permissive to RSV infection (1, 
21). Taken together, these results demonstrate lung DCs and AMs are permissive to BRSV 
infection and support viral replication in vivo. 
Previously, we have reported that neonatal MDDCs and lung tissue derived DCs 
differ phenotypically. Lung DCs express higher levels of CD80/86, MHC class 1 and MHC 
class II compared to mature MDDCs (9). After in vivo BRSV infection, we report here a 
significant increase in CD 14 expression at d 3 PI, which decreases by d 5 PL This 
observation is reminiscent of data demonstrating an increase in TLR4 expression on 
monocytes isolated from RSV infected children during the acute phase of infection (12). 
Together, these data are supported by the known trimeric clustering of CD 14, MD2 and 
TLR4 on the surface of cells (38). In the present study, expression of DEC-205, MHC class I 
and CD80/86 were not significantly increased over controls, though a trend for increased 
expression of these molecules by day 5 PI can be observed. MHC class II was expressed at 
low levels on lung DCs from BRSV infected lambs and control lambs. There was no 
observed phenotypic modulation of bovine MDDCs exposed to BRSV (Snook strain) as 
evidenced by the lack of altered MHC class I, MHC class II and CD80/86 expression (43). 
However, infection of human monocyte or cord blood derived DCs with human RSV resulted 
in increased expression of MHC class I and II, CD80 and CD86 (14, 21). Taken together, in 
vivo and in vitro infection of DCs may result in quantitatively different surface antigen 
expression. 
Mature DCs are potent inducers of an adaptive immune response to microbial 
infection in the lung microenvironment. As a functional measure of maturation state, isolated 
lung DCs from control and BRSV infected lambs were incubated with FITC-OVA and FITC-
dextran. Immature DCs are known to actively take up antigen via macropinocytosis and 
receptor-mediated endocytosis (20). The findings that isolated lung DCs from d 3 infected 
lambs phagocytosed significantly less FITC-OVA than controls with no difference at d 5 
suggest that isolated lung DCs from BRSV infected lambs are initially inhibited from 
phagocytosing antigen via macropinocytosis early after infection. This finding is supported 
by work in mice infected with RSV, where isolated lung DCs were reported to have low 
FITC-dextran uptake after 10 d of viral infection (3). In contrast to FITC-OVA, uptake of 
FITC-dextran via mannose receptor mediated endocytosis was lower and not significantly 
altered. 
RSV infection is a known inducer of inflammatory and immunomodulatory mediators 
in APCs in vitro (1, 14, 43). In the present study, we quantitated mRNA levels present in 
isolated lung DCs and AMs after BRSV infection. Alveolar macrophages produced 
significantly more IL-6 mRNA transcripts when compared to lung DCs. In addition, the 
induction of IL-12p40 mRNA within AMs was larger than levels detected within lung DCs. 
In general, BRSV infection induced a 1.5 to 2-fold increase in the expression of IL-ip, IL-6, 
IL-8, IL-12p40 and TNFa mRNA transcripts within lung DCs. Previous studies using human 
monocyte or cord blood derived DCs report similar cytokines and chemokines being 
produced after RSV infection (1, 14). Our results are similar to the cytokine mRNA profile 
observed in vitro by BRSV infection of bovine MDDCs (43). Interestingly, we observed 
increases in both IL-4 and IL-10 gene transcription within lung DCs after BRSV infection. 
Increased levels of IL-4 protein in nasal washes from RSV infected children have been 
reported though the exact cell source was not determined (13). Human plasmacytoid DCs 
isolated from peripheral blood mononuclear cells were infected with RSV and were reported 
to produce IL-4 after a 24 h exposure to the virus (14). Thus, it is plausible that DCs are a 
significant source of IL-4 during RSV infection in neonates. 
Accumulating experimental data suggest that severe RSV infections early in 
childhood may predispose these children later on to develop recurrent wheezing, asthma or 
other chronic pulmonary disorders (36). The progression of RSV disease is associated with a 
type II cytokine response and we report here that lung DCs are a likely source of IL-4 and IL-
10 observed after infection. It is has been suggested that the type II cytokine response after 
RSV infection predisposes these children to future pulmonary problems. Recently, studies 
have associated severe RSV infections with IL-4 haplotypes and/or polymorphisms (5, 19) 
further supporting the importance of IL-4 during RSV infections. Taken together, our results 
suggest that in vivo RSV infection may induce neonatal lung DCs to produce non-protective 
cytokine responses that may result in enhanced host susceptibility to secondary infections or 
chronic pulmonary diseases such as allergies or asthma. 
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Table 1. Primer sequences for ovine target and endogenous control genes 
Primer Sequence (5'- 3') Length (bp) Accession No. 
IL-1(3 Forward 
IL-1(3 Reverse 
AT GGGT GTT CT GC AT GAG 
AAGGCC AC AGGAAT CTT G 
63 OAIL1BMR 
IL-4 Forward 
IL-4 Reverse 
GG ACTT GAC AGG AAT CTC 
CT C AGCGT ACTT GT ACT C 
80 OAIL4MRNA 
IL-6 Forward 
IL-6 Reverse 
G AGTT GC AGAGC AGT AT C 
GGCT GG AGT GGTT ATT AG 
75 OAINT6A 
IL-8 Forward 
IL-8 Reverse 
A AGCT GGCT GTT GCT CT C 
GGC AT CG A AGTT CT GT ACT C 
94 OAIL8 
IL-10 Forward 
IL-10 Reverse 
GAT GCC AC AGGCT GAGAACC 
GCGAGTT C ACGT GCT CCTT G 
53 OAU11421 
IL-12p40 Forward 
IL-12p40 Reverse 
AAGT C ACAT GCC AC AAGG 
C ACTCC AGAAT GAGCT GT AG 
72 AF004024 
TNFcx Forward 
TNFa Reverse 
CT CAT CT ACTCGC AGG TCCTC 
ACT GCAAT GCGGCT GAT GG 
86 OATNFAR 
ovRP S15 Forward 
ovRPSIS Reverse 
TACAACGGCAAGACCTTCAACCAG 105 
GGGCCGGCC AT GCTTT ACG 
* 
BRSV 
NS2 Forward 
NS2 Reverse 
ACC ACT GCT C AGAGATT G 
AAT GT GGCCT GT CGTT CAT CG 
155 NC 001989 
* Ovine ribosomal protein S15 mRNA sequence provided by Dr. Sean Limesand, Dept. of 
Pediatrics, University of Colorado Health Sciences Center, Perinatal Research Center, 
Aurora, CO. 
FIG. 1. BRSV antigen co-localizes with CDllc+ dendritic cells in the lungs of neonatal 
lambs. Neonatal ovine lung cryosections were immunofluorescently stained with a primary 
antibody directed against CDllc (C, F, I) followed by a secondary antibody fluorescently 
labeled with Alexa Fluor 633 (red). Directly conjugated BRSV-FITC (B, E, H) antibody 
(green) was used to identify cells containing BRSV. Co-expression of CD I lc and the virus is 
shown by yellow. Multi-color immunofluorescence staining shows dual labeled DCs (A, D, 
G) and nuclear staining with DAPI (blue). The enlarged view (D, E, F) is from the inset 
white box (A) and an additional and different enlarged view (G, H, I) reveals more CDllc 
and BRSV co-localization. Data are representative of twelve lambs. Scale bars: A-C, 20 fxM; 
D-I, 10 jaM. 
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FIG. 2. BRSV replicates within lung dendritic cells (DCs) and alveolar macrophages 
(AMs). Isolated lung DCs and AMs were lysed in RLT buffer and total RNA isolated. 
Oligo(dT) cDNA and BRSV NS2 specific primers with SYBR Green chemistry were used 
for quantification of viral replication. Lung DCs supported BRSV replication, but less than 
AMs. Data are representative of six lambs. 
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FIG. 3. BRSV infection of neonatal ovine lungs induces maturation of CDllc+ lung DCs. 
Lung DCs were sorted magnetically to purify CD1 lc+ cells from digested neonatal lung 
suspensions from controls, day 3 post inoculation (PI) or day 5 PI lambs. Flow cytometric 
analysis of surface antigen expression revealed that eighty five percent of the sorted lung 
DCs co-expressed CDllc and DEC-205 (A). Statistical analysis indicated a higher mean 
fluorescence intensity (MFI) expression of CD 14 on lung DCs isolated at day 3 PI when 
compared to controls or day 5 PI lung DCs (B) (*P<0.05). MHC class I and CD80/86 
expression was higher on isolated lung DCs from day 5 PI lambs. Each column represents 
the average of the MFI staining for the indicated cell surface antigen minus the MFI staining 
of the appropriate isotype control. Data are representative of six lambs per experimental 
group. 
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FIG. 4. Uptake of FITC-ovalbumin (FITC-OVA) and FITC-dextran by isolated lung DCs. 
Magnetically sorted CDllc+ lung DC cell numbers were adjusted to lxl05 cells per ml and 
incubated with either FITC-OVA or FITC-dextran for 1 h at 37°C or 4°C. Data are expressed 
as delta mean fluorescent intensity (MFI) values, which represent the 37°C MFI values minus 
the 4°C MFI values. Statistical analyses indicate that lung DCs at day 3 post inoculation (PI) 
endocytosed less FITC-OVA than either the controls or day 5 PI lung DCs (*P<0.05). Data is 
representative of six lambs per treatment group. 
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FIG. 5. Quantification of cytokine responses in lung dendritic cells (DCs) and alveolar 
macrophages (AMs) isolated after in vivo BRSV infection. Isolated lung DCs or AMs were 
resuspended in RLT buffer and total RNA isolated. After reverse transcription, oiigo(dT) 
cDNA and ovine specific primers with SYBR Green master mix were used to quantify the 
genes of interest. mRNA gene expression is shown as a fold change relative to cells from 
control lambs. Both IL-10 and IL-4 gene expression in lung DCs are induced after BRSV 
inoculation. AMs produce greater amounts of IL-6 when compared to lung DCs. Data are 
representative of six lambs per time point. (*P<0.05) 
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CHAPTER FOUR. NEONATAL OVINE ALVEOLAR MACROPHAGES 
ARE MODULATED BY BRSV IN VIVO AND IN VITRO TO PRODUCE 
PROINFLAMMATORY AND IMMUNOMODULATORY CYTOKINES 
A paper to be submitted to Viral Immunology 
Sasha J. Each1'3, Alicia Olivier2, Jack M. Gallup2, Mark R. Ackermann2, Howard D. 
Lehmkuhl3, and Randy E. Sacco1'3. 
Abstract 
Respiratory syncytial virus (RSV) induces a potent production of inflammatory and 
immunomodulatory mediators in the lung that are pronounced in neonatal infants. Alveolar 
macrophages (AMs) are a crucial component in the production of these mediators and 
facilitate the induction of the immune response to RSV. In the present study, neonatal AM 
cytokine and chemokine responses were modulated by BRSV in vivo and in vitro, and were 
shown to be qualitatively different from those responses induced by TLR3 and TLR4 
agonists. Initially, AM responses were compared after in vivo human RSV A2 or bovine 
RSV (BRSV) 375 infection of neonatal lambs. Both strains of the virus induced a mixture of 
proinflammatory (IL-1(3, IL-6, IL-8, IL-12p40, TNFa) and immunomodulatory (IL-4, IL-10) 
mediators. In addition, BRSV modulation of neonatal AM cytokine responses in vivo was 
compared to in vitro data. Neonatal AMs transcribed less IL-4, IL-6, IL-12p40, and TNFa 
but more IL-8 mRNA after in vitro BRSV exposure when compared to gene expression 
'immunobiology Graduate Program, Iowa State University, Ames, Iowa. 
department of Veterinary Pathology, Iowa State University, Ames, Iowa. 
^Respiratory Diseases Research Unit, National Animal Disease Center, Agricultural 
Research Services, United States Department of Agriculture, Ames, Iowa. 
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observed in vivo. Both neonatal and adult AMs were permissive to in vitro BRSV infection 
and the virus was demonstrated to actively replicate within these cells. Both neonatal and 
adult AMs infected with BRSV showed qualitatively different cytokine and chemokine gene 
transcription when compared to responses elicited by TLR3 and TLR4 agonists. Treatment of 
neonatal AMs with recombinant IL-4 during BRSV infection resulted in significantly more 
IL-1(3, IL-6, and IL-10 mRNA transcribed when compared to AMs infected with BRSV 
alone. Together, these results suggest AM responsiveness to BRSV does not differ with age. 
However, levels of cytokine and chemokine expression do differ between neonates and 
adults when AMs are stimulated with TLR agonists. In addition, these data indicate that 
neonatal AMs contribute to the mixture of proinflammatory and immunomodulatory 
mediators produced after RSV infection and the presence of IL-4 at the time of infection 
enhances IL-1(3, IL-6 and IL-10 gene transcription. Taken together, these results indicate in 
vivo and in vitro BRSV modulation of neonatal AM cytokine and chemokine responses 
differ quantitatively. 
Introduction 
Infants and young children are commonly infected with respiratory syncytial virus 
(RSV), which causes severe lower respiratory tract infections manifesting itself as acute 
bronchiolitis and pneumonia (6, 35). RSV tropism for the lower respiratory tract is supported 
by active replication within lung epithelial cells, inducing production of mediators that are 
chemotactic to cells of the immune system. Infiltration of antigen presenting cells, 
lymphocytes and mononuclear cells are detected within lung tissue after RSV infection (16, 
33). Within the alveolar space, alveolar macrophages (AMs) play a crucial role in clearance 
of respiratory pathogens as well as the production of proinflammatory and 
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immunomodulatory mediators upon stimulation by microorganisms (36). The presence of 
AMs in the lower respiratory tract enables them to come in contact with RSV. In vivo data 
from adult humans and neonatal lambs confirm the presence of RSV within AMs (24). AMs 
infected in vitro with RSV has been documented in human (23), mouse (31), and guinea pigs 
(5) and the production of proinflammatory mediators including IL-6 , IL-8, TNFa, RANTES 
(1,9, 14, 20) and immunomodulatory IL-10 (25) has been induced in these cells. Recently, 
human AMs were discovered to produce IL-4 after phorbol-12-myristate-13 -acetate and 
calcium ionophore stimulation (27). The proinflammatory cytokines and immunomodulatory 
mediators that are produced by AMs make them a potent immune cell that could have 
possible effects on the polarization of the immune response to RSV. 
Neonatal infants have an ineffective immune response to RSV, as evidenced by the 
prevalence of recurrent infections during childhood (13). Children with severe RSV 
infections were shown to have predominant Th2 cytokine response leading to progression of 
the disease (2, 28). Accumulating evidence indicates AMs are potent inducers of cytokine 
and chemokine responses after RSV infection. Although RSV has been shown to infect AMs, 
there are discrepancies within data reported from in vivo or in vitro derived assays. The aim 
of these studies was to characterize BRSV induced AM cytokine responses following in vivo 
or in vitro infection. In vivo, neonatal lambs were infected with either human RSV A2 or 
BRSV. In vitro, both neonatal and adult AMs were susceptible to infection by BRSV. BRSV 
induced responses were quantitatively compared to TLR3 and TLR4 agonists, UV 
inactivated virus, or exogenous IL-4. These results demonstrate that AM cytokine and 
chemokine responses are modulated by BRSV both in vivo and in vitro. 
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Material and Methods 
Animals and experimental procedure 
In vivo studies 
Healthy two to four day old lambs of mixed Rambouillet and Polypay breeds were 
used for the following experiments. Lambs received Naxcel (2.2 mg/kg once a day, 
intramuscular) to prevent secondary bacterial complications (34) as previously done in 
premature lambs (19). Lambs were bottle feed four times a day with commercial milk 
replacer. During inoculation, lambs received an intratracheal inoculation of either 22 ml of 
BRSV 375 inoculum or sterile medium through a sterile 30 cc syringe and 21-gauge needle. 
Lambs inoculated with BRSV 375 were necropsied at day three (n=10) and day five (n=10) 
post-infection, including control lambs (n-10). 
Human RSV was inoculated into lambs using a bronchoscope procedure after 
anesthetization with xylazine (0.5 mg/kg) and placed in right lateral recumbency. A 
bronchoscope was placed into the trachea and passed into the right main stem bronchus. The 
bronchoscope was inserted through bronchial bifurcations until the airways narrowed to a 
smaller diameter than the scope. Human RSV Strain A2 inoculum or sterile medium was 
slowly administered through the port using a 10 ml syringe, followed by a 5 ml sterile saline 
flush. The bronchoscope was removed and the lamb remained in right lateral recumbency for 
5 min. The anesthesia was reversed with tolazoline (4 mg/kg). Lambs inoculated with hRSV 
(n=4) and controls (n=4) were necropsied at day five post-infection. All lamb lungs were 
aseptically removed, lavaged with sterile PBS and the cells collected into sterile 50 ml 
conical tubes. 
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In vitro studies 
Healthy two to four day old lambs (n=8) and two to nine year old adult sheep (n=4) of 
mixed Rambouillet and Polypay breeds were used for the following experiments. At the time 
of necropsy, the lungs were aseptically removed, lavaged with sterile PBS and the collected 
cells were pipetted into sterile 50 ml conical tubes. 
Viral Inoculum 
Bovine RSV (BRSV) 375 was propagated on adherent bovine turbinate cells. By 
seven days of incubation or when over 90% of viral induced cytopathic effect was observed, 
flasks were frozen at -80C. Within two days, the flasks were thawed and all media pooled. 
After thorough mixing and sterile filtration, viral inoculum was aliquoted and stored at -80C. 
Using standard plaque assay, the tissue culture infectious dosage (TCID50), for the virus was 
determined to be 104 9 TCID50 per ml (3.97 x 104 plaque forming units (pfus)/ml). The viral 
inoculum was negative for BVDV by PCR (data not shown). For in vitro studies, BRSV 375 
was inactivated by UV irradiation using a Stratagene UV Stratalinker 1800 (3000 
watts/cm2; Stratagene, La Jolla, CA) on the auto-crosslink mode. Twenty-two ml of BRSV 
375 in a sterile 150 x 15 mm petri dish was irradiated ten times, and the dish was gently 
swirled each time in between treatments. Human RSV A2 strain (2 x 107pfus /ml) was kindly 
provided by Dr. Steve Varga, University of Iowa, Iowa City, Iowa. 
Enrichment of alveolar macrophages 
Lavaged cells were centrifuged in 50 ml conical tubes at 805 x g for 15 min at 4°C. 
The supemants were aspirated off and cells resuspended in 5 ml of AM media (RPMI 1640 
supplemented with 2% lamb serum, 2 mM L-glutamine, 25 mM HEPES and 1% antibiotic-
antimycotic solution (all from Gibco, Carlsbad, CA). Cells were transferred to a large (150 x 
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15 mm) sterile petri dish containing 30 ml of sheep specific AM media. After 2 h incubation 
at 5% CO2 and 37°C, any nonadherent cells and the media were aspirated off and adherent 
AMs washed in warm, sterile PBS. The cells were released from the bottom by the addition 
of PBS and gentle scraping with a sterile rubber policeman. The AMs and PBS were pipetted 
into 50 ml conical tubes and centrifuged at 453 x g for 5 min at 4°C. The supemants were 
aspirated off and AMs were resuspended in 1-2 ml of AM media then enumerated on a 
hemacytometer. 
In vitro treatment stimulation of AMs 
Sterile, ninety-six well round bottom plates were used for the in vitro assays. AMs 
were adjusted to 1 x 106 cells in 200 jil of sheep alveolar macrophage media. The cells were 
exposed to Escherichia coli LPS 055:B5 (1 pig/ml; Sigma-Aldrich, St. Louis, MO), Poly IC 
(Ipig/ml; Amersham Biosciences, Piscataway, NJ), BRSV 375 at a multiplicity of infection 
(moi) of 2, BRSV 375 (moi of 2) and recombinant human IL-4 (10 ng/ml; R&D Systems, 
Minneapolis, MN) and UV inactivated BRSV 375 (UV-BRSV) at a moi of 1. After 90 min of 
incubation, BRSV treated wells were washed by aspiration of the supemant and cells rinsed 
with warm RPMI. 200 j-d of fresh AM media was replenished and in appropriate wells fresh 
IL-4 was added. Supemants were collected and 300 (il of RLT buffer, from the RNeasy Mini 
RNA Isolation kit (Qiagen, Valencia, CA), were added to cells and collected at 2, 6,18 and 
24 h. 
Immunohistochemistry 
Alveolar macrophages (1 xlO6 cells) were incubated in one well chambers slides 
(Nalge Nunc International, Naperville, IL) with 2 ml AM media and BRSV at a moi of 1. 
After 90 min incubation at 5% CO2 and 37°C, the any remaining extracellular virus and 
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media was aspirated off and the cells washed in warm RPMI. Two ml of fresh AM media 
was added to each chamber and slides were incubated again at 5% CO2 and 37°C for a total 
of 24 h. The media was aspirated off and the slides were washed with PBS and fixed for 10 
min with 100% methanol at room temperature. The slides were dried and rehydrated in IX 
Tris buffer and blocked with normal goat serum (Kirkegaard Perry Labs, Gaithersburg, MD) 
for 30 min at room temperature. The slides were washed in IX Tris buffer and incubated 
with polyclonal antibody BRSV conjugated to FITC (50 p,l; VMRD Inc., Pullman, WA) at 
37°C for 30 min. To visualize nuclei, slides were washed with IX Tris buffer and incubated 
with 4', 6-diamidino-2-phenylindole, dilactate (DAPI, 300 nM; Molecular Probes) for 5 min 
at room temperature. The slides were washed with IX Tris buffer and cover slips mounted 
with a 50-50 glycerin and PBS solution. Alveolar macrophages were examined using a Leica 
TCS-NT confocal scanning laser microscope (Leica Microsystems, Inc., Exton, PA). Images 
were prepared using Adobe Photoshop version CS and InDesign version 3. 
Total RNA Extraction and cDNA synthesis 
Enriched AMs were pelleted in sterile 1.5 ml eppendorf tubes. Cells were 
resuspended in 350 pil of RLT buffer from the RNeasy Mini RNA Isolation kit (Qiagen, 
Valencia, CA) and stored at -80°C. Total RNA was isolated using the RNeasy Mini RNA 
Isolation Kit (Qiagen) according to manufacturer's instructions. Contaminating genomic 
DNA was removed during RNA isolation using an on-column RNase-Free DNase I digestion 
set (Qiagen) according to manufacturer's instructions. Total RNA was eluted by the addition 
of 40 ill of DNase-RNase free water. 500 ng to 1 pig of total RNA from each sample was 
reverse transcribed using oligo(dT)i2-is primers (Invitrogen, Carlsbad, CA). 
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Cytokine and BRSV NS2 mRNA quantification 
Primers were designed specifically for SYBR Green quantification using the Primer 
Select program (DNASTAR Inc., Madison, WI) with suggested parameters for SYBR Green 
chemistry that included product size no larger than 100-150 base pairs and a 50°C annealing 
temperature. Ovine ribosomal protein SI5 was chosen as the endogenous control for the 
genes of interest, which are listed in Table 1. Oligo(dT) cDNA was diluted 1:10 in DNase-
RNase free water and 2 ill used for quantification. SYBR Green PCR Master Mix (Applied 
Biosystems, Foster City, CA) was used according to manufacturer's instructions. An Applied 
Biosy stems 7300 Real Time PCR Systems machine was used with the same amplification 
conditions for all genes of interest: 10 min at 95°C, 15 sec at 95°C, 40 cycles of 1 min at 
50°C, with a dissociation step of 15 sec at 95°C, 30 sec at 50°C, 15 sec at 95°C. Final relative 
quantification was calculated using the 2"aaCT method (18) where the amount of target gene is 
normalized to an endogenous control (ovine ribosomal protein S15) and expressed relative to 
control cells. Primers were validated on the Applied Biosystems 7300 machine by using 
serial dilutions of total RNA with ovine ribosomal protein S15 and target gene primers, 
whose values were plotted as the log input amount vs. ACR values (target gene CJ -
endogenous control CT) for relative efficiency. Only primers with a slope of less than 0.1 
were used, due to similar amplification efficiencies as the endogenous control. 
In sterile eppendorf tubes, 20 pel of total RNA from BRSV 375 inoculum and BRSV 
oligo(dT) cDNA were treated with RNase If (1 unit/pil; New England Biolabs, Ipswich, MA) 
or untreated and all four samples were incubated for 30 min at 37°C. The digestion of single 
stranded RNA was stopped by heating the tubes at 70°C for 20 min. Removal of the RNase 
enzyme was performed by Microcon column exclusion (100 U columns; Millipore, Billerica, 
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MA) according to manufacturer's instructions. Samples were quantified using BRSV NS2 
primers and SYBR Green chemistry as previously described above. No amplification of 
genomic BRSV NS2 was observed (data not shown). 
Statistical analysis 
Data were expressed as a fold change relative to control cells. Samples were 
compared using a one-way ANOVA comparisons. Significance was determined by P < 0.05. 
Results 
In vivo RSV infection induces a mixed cytokine response in alveolar macrophages 
To quantify the cytokine response of neonatal AMs after RSV infection, lambs were 
first inoculated with either BRSV (3 or 5 d) or human RSV strain A2 (5 d). AMs were 
lavaged from the lungs and plated for two h in AM media. Nonadherent cells were removed, 
the AMs lysed in RLT buffer and total RNA harvested. Oligo(dT) specific cDNA was 
transcribed from the total RNA and used for quantification. Proinflammatory and 
immunomodulatory cytokines were detected using ovine gene specific primers and SYBR 
Green chemistry for relative quantification. After BRSV infection, AM produced a 5 to 25-
fold increase in proinflammatory IL-1(3, IL-6, and IL-12p40 gene transcription but only a 1.5 
to 3-fold increase in IL-8 and TNFa mRNA transcripts (Fig. 1 A). Significant differences in 
immunomodulatory IL-4 and IL-10 mRNA transcripts were observed between three and five 
d post-infection (PI) with BRSV (Fig. IB). Interestingly, when comparing cytokine 
expression induced in vivo by different RSV strains, specifically BRSV and human RSV A2 
(hRSV), both induced a 15 fold increase in IL-4 mRNA transcripts at d 5 PI. Human RSV 
induced a 1-2 fold increase in IL-1(3, IL-6, IL-8, IL-10, IL-12p40 and TNFa gene 
transcription. Overall, both in vivo BRSV and human RSV A2 infections in young lambs 
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induced a mixture of proinflammatory and immunomodulatory cytokine gene transcripts in 
AMs. 
In vitro immunofluorescence detection of BRSV infected AMs 
In vitro assays utilizing AMs exposed to BRSV were established in the following 
experiments. Lavaged cells were harvested from healthy neonatal lamb and adult sheep, 
incubated for two h and nonadherent cells washed off. Adherent AMs were gently removed 
with a sterile rubber policeman and enumerated. Cells were adjusted to 1 x 106 and incubated 
in chamber slides with 1ml of AM media. Cells were exposed to BRSV at a moi of 2 for 90 
min after which the virus was removed by washing with warm RPMI. After 24 h of total 
incubation, slides were fixed and subsequently stained for the presence of BRSV antigen 
using a polyclonal anti-BRSV directly conjugated to FITC (BRSV-FITC). A majority of the 
neonatal AMs stained with the BRSV-FITC antibody as shown in Figure 2A and B. Bright 
BRSV-FITC (green) staining was evident in the cytoplasm of the infected AMs. Alveolar 
macrophages that were not exposed to BRSV were included as negative controls (Fig. 2C). 
BRSV infected adult AMs had similar staining patterns as the neonatal lamb AMs (data not 
shown). Overall, AMs from both neonatal lambs and adult sheep are permissive to BRSV 
infection in vitro. However, additional experiments were required to determine whether AMs 
support active viral replication after in vitro BRSV infection. 
AMs support active viral replication in vitro 
Upon initiation of replication, the RNA dependent RNA polymerase transcribes the 
RSV negative sense genome in the 3' to 5' direction. Large amounts of the nonstructural 
proteins NS1 and NS2 mRNA are produced during viral replication, which is as a result of 
the genome's transcriptional polarity, where the genes on the 3' end are transcribed in greater 
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amounts than the 5' genes. To detect in vitro viral replication within AMs, primers were 
designed to the NS2 mRNA of BRSV and relative quantification was performed utilizing 
incorporation of SYBR Green chemistry. Both adult and neonatal AMs were exposed to 
BRSV in vitro for 90 min and the supernant was removed. The cells were washed in warm 
RPMJ to remove any remaining extra cellular virions and fresh media was added. The 
supemants and cells were harvested after 2,6, 18 and 24 h of incubation and UV-BRSV was 
used as a control for the experiments. Neonatal AMs were incubated with BRSV or UV-
BRSV and live BRSV actively replicated compared to UV-BRSV exposed AMs (Fig. 3A). 
Statistical differences in NS2 mRNA production were observed in UV-BRSV and live BRSV 
treated AMs. Adult AMs exposed to BRSV produced similar amounts of NS2 mRNA when 
compared to the neonatal AMs exposed to BRSV (Fig. 3B). Significant differences in NS2 
production were detected between the adult AMs treated with BRSV or UV-BRSV. Both 
neonatal and adult AMs support BRSV replication in vitro as demonstrated by similar 
amounts of NS2 mRNA transcribed at early time points after viral exposure. 
BRSV modulates in vitro cytokine response of neonatal AMs 
AMs harvested from neonatal lambs were exposed to BRSV or one of several 
different stimuli in vitro to determine the modulation of cytokine gene expression after 
BRSV infection. The data reported herein demonstrate that BRSV induces a quantitatively 
different cytokine response than TLR3 or TLR4 stimuli (Fig. 4). In general, 
proinflammatory IL-1J3, IL-12p40 and TNFa gene transcription increased 2-5 fold after 
BRSV exposure (Fig. 4A). Of note, IL-10, IL-8 and IL-6 mRNA transcripts were increased 
4-10 fold upon viral infection (Fig. 4A and 4B). Interestingly, active viral replication was not 
necessary to induce cytokine gene transcription. AMs exposed to either live BRSV or UV-
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BRSV expressed similar levels of mRNA transcripts of IL-4, IL-6, IL-12p40 and TNFa (Fig. 
4A and 4B). Statistical differences were noted with UV-BRSV inducing more IL-1|3, IL-8 
and IL-10 gene transcription than live BRSV. These results are reminiscent of reported data 
demonstrating that BRSV NS1 and NS2 proteins inhibit host interferon a and (3 (IFN a/|3) 
responses (30), therefore it is plausible to suggest that BRSV inhibits specific cytokine 
expression during active replication. LPS is a known inducer of TLR4 signaling and Poly IC 
(synthetic double stranded RNA) has been shown to signal through TLR3. These two 
pathways of cytokine induction produced more IL-1 (3, IL-6, IL-8, IL-10 and IL-12p40 gene 
transcription when compared to BRSV. Lastly, exposure of AMs to exogenous IL-4 during 
BRSV infection significantly increased IL-1J3, IL-6 and IL-10 gene transcription compared to 
AMs exposed to BRSV alone. Taken together, results indicate that the BRSV induced 
cytokine mRNA expression of neonatal AMs differs from that induced by TLR3 or TLR4 
agonists. 
Adult AM cytokine responses quantitatively differ from neonates 
AMs were harvested from adult sheep lungs and incubated in vitro with BRSV, LPS, 
Poly IC or UV-BRSV. These data demonstrate that BRSV induced cytokine gene 
transcription after BRSV exposure differs qualitatively from TLR3 (Poly IC) and TLR4 
(LPS) induced responses (Fig. 5). In general, a 2-5 fold increase in IL-6 and IL-4 gene 
transcription was observed in adult AMs (Fig. 5A and 5B). A 1-2 fold increase in IL-1|3, IL-
8, IL-10, IL-12p40, and TNFa was seen after viral infection (Fig. 5A and 5B). Of note, less 
IL-8 gene transcription was induced by BRSV in the adults when compared to neonatal AMs. 
In addition, live or UV-BRSV induced adult sheep AM gene transcription indicating that 
viral replication was not necessary for BRSV induced cytokine expression. LPS stimulation 
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of the adult AMs via TLR4 induced significant cytokine gene transcription of IL-6, IL-8, IL-
10, IL-12p40 and TNFa when compared to BRSV infected AMs. TLR3 induced signaling of 
AMs led to similar mRNA levels induced by BRSV infection for IL-1(3, IL-4, IL-6, IL-8, and 
IL-12p40. Significant differences in Poly IC induced gene transcription compared to BRSV 
infected AMs were noted for IL-10 and TNFa. In general when comparing adult and 
neonatal AMs, adult cells produced lower levels of cytokine gene transcripts after viral or 
TLR agonist stimulation. 
Discussion 
In the present study, BRSV modulation of neonatal AM cytokine responses in vivo 
and in vitro were determined. Neonatal lamb AMs were induced to transcribe a mixture of 
proinflammatory and immunomodulatory mediators after in vivo infection with either BRSV 
or hRSV. In vivo infection with BRSV is a potent inducer of both IL-4 and IL-6 gene 
expression in AMs. To determine whether the in vitro responses would mirror these results 
observed in vivo, neonatal and adult AMs were exposed to BRSV in vitro. Both neonatal and 
adult AMs were permissive to in vitro BRSV infection and the virus was demonstrated to 
actively replicate within these cells. Knowing that the virus was actively replicating within 
the AMs, modulation of cytokine responses was investigated. Quantitatively different 
cytokine responses were induced from neonates when compared to the in vivo data. Neonatal 
AMs transcribed less IL-4, IL-6, IL-12p40, and TNFa but more IL-8 mRNA after in vitro 
BRSV exposure when compared to gene expression observed in vivo. Adult AMs produced 
less IL-8, IL-12p40, and TNFa but more IL-4 mRNA transcripts after in vitro BRSV 
infection compared to the cytokine expression seen in the neonatal AMs. TLR3 and TLR4 
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agonists induced quantitatively different proinflammatory and immunomodulatory cytokine 
responses than BRSV in vitro for both neonatal and adult AMs. Taken together, BRSV 
modulates AM cytokine responses both in vivo and in vitro, though a more IL-4 gene 
transcription is observed in vivo. 
RSV replication within cells, specifically human epithelial cells lines in vitro has 
been studied extensively to elucidate the induction of cytokine and chemokine production 
after viral infection. Infected human epithelial cells produce IL-la, IL-|3, TNFa and 
chemokines IL-8, RANTES, TARC, MCP-1, MlP-la and MP-1(3 (22, 26, 37). Cell lines 
have also been utilized to study RSV activation of NF-KB. Upon RSV infection, NF-KB 
activation occurs though nuclear translocation of Rel A, p50 and c-Rel (3, 10,12). Few 
studies have investigated RSV modulation of NF-KB and cytokine gene expression in lung 
antigen presenting cells after infection. One study demonstrated the importance of murine 
AMs early on in RSV infection. In vivo, murine AMs were chemically depleted before RSV 
infection, and lung homogenates isolated after 1.5 h of RSV or UV-RSV inoculation (12). 
Activation of NF-KB was not detected when AMs were depleted. Early activation of NF-KB 
was observed in wild type mice either with live or UV-RSV inoculum and activation was 
attributed to AMs (12). Thus, these in vivo studies indicate that AMs are critical for the 
initial cytokine response to RSV within the lungs. 
Neonatal lambs were infected with two different strains of RSV and AM cytokine 
gene expression was quantitated. The different RSV strains, BRSV 375 and human RSV A2, 
were used to inoculate lambs intratracheal^ and by bronchoscope respectively. Both RSV 
strains induced a combination of proinflammatory (IL-1(3, IL-6, IL-8, IL-12p40, TNFa) and 
immunomodulatory (IL-4, IL-10) cytokine responses at day 5 pi. The mixed cytokine 
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response has been documented in humans and mouse models of RSV infection, though 
cytokines were measured from PBMCs (15, 32). Interestingly, BRSV is a potent inducer of 
IL-4 and IL-6 gene transcription in vivo. These data are supported by other studies 
documenting the presence of IL-4 and IL-6 in nasal washes from infected children (11). 
Differences were observed in the level of cytokine mRNA transcripts expressed after BRSV 
and hRSV inoculation. However, both strains induced a mixed cytokine response. Overall, 
RSV modulates AMs in vivo to produce a mixture of proinflammatory and 
immunomodulatory mediators. 
Previously we have shown that BRSV actively replicated in AMs isolated after in 
vivo BRSV infection of neonatal lambs (Chapter 3). To further investigate the effects of viral 
replication on AMs, in vitro assays utilizing neonatal lamb AMs inoculated with BRSV were 
established. Detection of active replication was observed by immunofluorscence microscopy 
and quantitative PCR. Alveolar macrophages were inoculated with BRSV for 90 min and any 
remaining virions were removed by aspirating the supemant, washing the cells and 
replenishing the media. The immunofluorescence data suggest that different subsets of AMs 
are permissive to RSV infection. To date, it remains unknown why some AMs are not 
infected with the virus, but one study suggests that the maturation state of the AM may make 
the cell more or less susceptible to RSV infection, stating that immature AMs are more 
permissive to RSV infection (5). Nonetheless, active replication of BRSV occurs in both 
neonatal lamb and adult sheep AMs exposed to the virus in vitro. We utilized detection of 
viral mRNA to confirm that BRSV was replicating within the AMs. Both neonatal and adult 
AMs supported active BRSV replication in vitro, although NS2 mRNA production decreased 
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in neonatal AMs at 24 h. By utilizing quantification of BRSV NS2 mRNA, we have 
demonstrated that neonatal and adult AMs both support BRSV replication in vitro. 
Previous studies have reported production of proinflammatory cytokines and 
chemokines from AMs infected in vitro with RSV. Human, mouse, and guinea pig AMs have 
been utilized for these in vitro assays. Production of IL-1(3, IL-6, IL-8, and TNFa mRNA and 
protein are produced in AMs after infection with RSV (1,9, 14, 25). Discrepancies exist 
whether or not live, replicating virus is needed for cytokine induction and AMs are harvested 
from different aged subjects, some using adult human, adult or juvenile small rodents for 
their studies (1, 14, 20, 31). Our study compares neonatal lambs and adult sheep in parallel to 
further investigate the effects of RSV on AMs. AMs were exposed in vitro to live BRSV, 
BRSV with exogenous IL-4, UV-BRSV, LPS or Poly IC. Both neonatal and adult AMs 
produced at least a 2-fold increase in gene expression of IL-1|3, IL-4, IL-6, IL-8, IL-10, IL-
12p40 and TNFa in response to exposure of both live or UV-BRSV. These results are similar 
to other studies that observe IL-6, IL-8 and TNFa expression induced from both live and UV 
or heat inactivated RSV exposed AMs (1,31). Thus, in vitro BRSV replication is not 
necessary for induction of RSV cytokine gene expression from neonatal and adult AMs. 
In the present study we quantitatively compared BRSV modulated cytokine gene 
transcription to TLR3 and TLR4 agonists. Recently, one study has reported RSV induces 
chemokine production of IL-8 and RANTES via TLR3 signaling in vitro using transfected 
TLR3 HEK 293 cells (29). RSV was also shown to up regulate expression of TLR3 on 
epithelial cell lines. TLR3 engagement initiates cytoplasmic recruitment of TRIF, leading to 
downstream activation and nuclear translocation of NF-KB family members and transcription 
of proinflammatory genes (21). Other studies have investigated the interaction of RSV and 
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TLR4. Engagement of TLR4 by affinity purified RSV A2 F proteins has been shown in vitro 
to stimulate production of IL-6 by human monocytes and peritoneal macrophages, though it 
is unknown whether this occurs specifically on AMs since they were not examined in these 
studies (17). TLR4 stimulation leads to activation of either MyD88 dependent or independent 
pathways, subsequent activation of NF-kB family members, and ultimately the transcription 
of proinflammatory mediators (21). As mentioned previously, studies have demonstrated that 
BRSV activates NF-KB signaling, but quantitative cytokine responses of lung APCs to 
BRSV and TLR agonists have not been compared in parallel. Our data demonstrate that 
BRSV modulates cytokine expression in neonatal and adult AMs differently than either 
TLR4 (LPS) or TLR3 (Poly IC) stimulation. Since BRSV has been shown to interact with 
TLR3 and TLR4, it is plausible to think that a quantitatively larger cytokine response may be 
elicited after BRSV infection compared with only TLR3 or TLR4 stimulation of AMs. BRSV 
induces a mixed cytokine and chemokine response in vitro, but modest transcription is 
observed when compared to TLR signaling. Our studies have demonstrated that BRSV 
modulates the AM cytokine response but further investigation is needed to determine what 
signaling molecules are modulated during BRSV infection. 
Previously we have shown that a type II cytokine response is induced in lung APCs 
after BRSV infection (7). Since the cytokine milieu of the lung environment is crucial in 
developing an appropriate immune response to RSV infection, we added exogenous IL-4 to 
our AM cultures. Interestingly, neonatal AMs exposed to BRSV and exogenous IL-4 
produced significantly more IL-1(3, IL-6, and IL-10 mRNA when compared to BRSV 
stimulation only. AMs exposed to IL-4 during BRSV infection leads to an enhancement in 
immunomodulatory IL-10 gene transcription, which could affect the outcome of the RSV 
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immune response. Recently, a study examined the effect of IL-4 on primary and secondary 
RSV infections in mice. In vivo expression of IL-4 was controlled by recombinant RSV, 
where the mouse IL-4 gene was inserted in between the F and G gene of RSV (4). During 
active viral replication, the IL-4 gene was transcribed and protein produced. The combination 
of IL-4 and RSV induced significant immunopathological lesions (peribronchiolitis, 
interstitial pneumonitis) and influx of inflammatory cells, mainly lymphocytes and 
macrophages, into the lungs of mice after primary infection (4). Further elucidation into the 
combined effects of IL-4 and BRSV on AM signaling remain to be determined. 
Our data and those of others indicate that RSV infection and replication can occur in 
other cell types besides lung epithelial cells (5, 8, 23). A predominant type II cytokine 
response is induced in children upon severe RSV infection. Cytokine cross talk between 
epithelial cells, lung APCs and other innate immune cells has important implications for the 
outcome and severity of the RSV infection. Our data demonstrate that RSV modulates AM 
cytokine responses and IL-4 enhances the proinflammatory and immunomodulatory 
cytokine response produced. 
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Table 1. Primer sequences for ovine target and endogenous control genes 
Primer Sequence (5'-3') Length (bp) Accession No. 
IL-1(3 Forward 
IL-1 p Reverse 
IL-4 Forward 
IL-4 Reverse 
AT GGGT GTTCT GC ATG AG 
AAGGCCAC AGGAAT CTT G 
GGACTT GAC AGGAATCTC 
CTC AGCGT ACTT GTACT C 
63 OAIL1BMR 
80 OAIL4MRNA 
IL-6 Forward 
IL-6 Reverse 
G AGTT GC AG AGC AGT AT C 
GGCT GG AGT GGTT ATT AG 
75 OAINT6A 
IL-8 Forward 
IL-8 Reverse 
A AGCT GGCT GTT GCT CTC 
GGC AT CG AAGTT CT GT ACTC 
94 OAIL8 
IL-10 Forward 
IL-10 Reverse 
GAT GCC AC AGGCT GAGAACC 
GCG AGTT C ACGT GCTCCTT G 
53 OAU11421 
IL-12p40 Forward 
IL-12p40 Reverse 
TNFa Forward 
TNFa Reverse 
AAGT C AC AT GCC AC A AGG 
C ACT CC AGAAT G AGCT GT AG 
CT CAT CT ACT CGC AGGTCCT C 
ACT GCAAT GCGGCT GAT GG 
72 AF004024 
86 OATNFAR 
RiboSIS Forward 
RiboS15 Reverse 
T AC AACGGC AAGACCTT C AACC AG 105 * 
GGGCCGGCC AT GCTTT ACG 
BRSV 
NS2 Forward ACC ACT GCT C AG AG ATT G 155 NC_001989 
NS2 Reverse AATGTGGCCTGTCGTTCATCG 
* Ovine ribosomal protein S15 mRNA sequence provided by Dr. Sean Limesand, Dept. 
of Pediatrics, University of Colorado Health Sciences Center, Perinatal Research Center, 
Aurora, CO. 
FIG. 1. Bovine RSV (BRSV) induced cytokine gene transcription quantitated from neonatal 
AMs. Neonatal lambs (n=10) were inoculated with BRSV and AMs isolated at 3 and 5 d 
post-infection (PI). Bronchial alveolar lavages were incubated for 2 h and AMs were 
enriched by plastic adherence. RLT buffer was used to lyse the cells and total RNA isolated. 
Oligo(dT) specific cDNA was used with ovine specific primers and SYBR Green chemistry 
to quantitate mRNA transcription of certain proinflammatory and immunomodulatory 
mediators. BRSV induced IL-1(3, IL-6, IL-8, IL-12p40 and TNFa gene transcripts with no 
differences at 3 and 5 d PI (A). Significantly more immunomodulatory IL-4 and IL-10 were 
transcribed at d 5 than d 3 after BRSV infection (B) (*P<0.05). 
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FIG. 2. Immunofluorescence staining of AMs infected with BRSV. Neonatal AMs were 
incubated in vitro with BRSV for 90 min. Cells were washed with warm RPMI and 
replenished with fresh complete media. After 24 h of incubation, cells were washed and 
fixed. Detection of BRSV (green) within AMs was observed by incubating the cells with 
polyclonal anti-BRSV fluorescently labeled with FITC and nuclei were identified by staining 
with DAPI (blue). Two color immunofluorescence was observed in BRSV treated AMs (A, 
B) but not in the control AMs (C). Scale bars: A-C, 5 |iM 
125 
(N 
î 
o 
ûû 
FIG. 3. Neonatal and adult AMs support BRSV replication in vitro. Neonatal (n=8) and adult 
(n=4) AMs were exposed to BRSV for 90 min and washed in warm RPMI. Fresh medium 
was added and cells were incubated for up to 48 h before harvest. Adherent cells were lysed 
with RLT buffer and total RNA isolated and used for oligo(dT) cDNA synthesis. 
Quantification of NS2 mRNA production was obtained with BRSV NS2 specific primers and 
SYBR Green chemistry. Both neonatal and adult AMs produce similar amounts of NS2 
mRNA during BRSV replication which are significant when compared to UV inactivated 
BRSV (*P<0.05) (A, B). 
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FIG. 4. Cytokine and chemokine responses from stimulated neonatal AMs. Neonatal AMs 
(n=8) were exposed to BRSV (moi of 2), BRSV with exogenous IL-4, LPS (1 fxg/ml), Poly 
IC (1 ng/ml) or UV inactivated BRSV (moi of 1) for up to 24 h. AMs exposed to BRSV were 
washed after 90 min, and new media with or without IL-4 was replenished on the cells. At 
the various time points, supernants were aspirated and cells lysed in RLT buffer. Total RNA 
was isolated and oligo(dT) cDNA transcribed and used for quantification of cytokines with 
ovine specific primers and SYBR Green chemistry. Proinflammatory (A) and 
immunomodulatory (B) mRNA transcripts were quantified after BRSV treatment. AMs 
exposed to BRSV induced production of all cytokines, but exposure to IL-4 during infection 
induced significantly more IL-1(3, IL-6 and IL-10 when compared to BRSV infected AMs 
(*P<0.05). Stimulation through TLR3 or TLR4 induced neonatal AMs to transcribe more IL-
1(3, IL-6, IL-8, IL-10, and IL-12p40 (*P<0.05). 
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FIG. 5. Quantification of proinflammatory and immunomodulatory mediators produced by 
stimulated adult AMs. Adult AMs (n=4) were exposed to BRSV (moi of 2), LPS (1 fxg/ml), 
Poly IC (1 [Ag/ml) or UV inactivated BRSV (moi of 1) for up to 24 h. AMs exposed to BRSV 
were washed after 90 min, and new medium was replenished. After each incubation, 
supernants were aspirated, cells lysed in RLT buffer and total RNA isolated. Oligo(dT) 
specific cDNA was transcribed and ovine specific primers with SYBR Green chemistry were 
utilized for quantification of proinflammatory (A) and immunomodulatory (B) mRNA 
transcripts. BRSV induced production of all proinflammatory and immunomodulatory 
mediators, but more than a 2-fold increase in gene expression was observed in IL-4, IL-6 and 
IL-10. Stimulation of TLR3 induced significantly more IL-10 and TNFa transcription than 
BRSV infected AMs (*P<0.05). LPS induction of TLR4 signaling induced significantly more 
IL-6, IL-8, IL-10, IL-12p40 and TNFa when compared to BRSV induced gene expression 
(*P<0.05). 
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CHAPTER FIVE. DISCUSSION 
Respiratory syncytial virus is the most prominent viral pathogen in infants and 
children causing severe lower respiratory tract infections and pneumonia (7). To date, there 
are no vaccines available and the immune response mounted to virus is ineffective due to 
recurrent infections throughout childhood (9). There is a need for neonatal models of natural 
infection with RSV and the data reported in this dissertation is derived from a neonatal lamb 
model of BRSV infection. Given the central importance of APCs in the initiation of the host 
immune response, these studies described here examined modulation of lung APCs by 
BRSV. Tissue derived DCs and MDDCs from neonatal lambs were first characterized and 
found to be similar in phenotype and function to their counterparts in other species. However, 
there were striking differences phenotypically and functionally between the tissue derived 
DCs and MDDCs. Secondly, neonatal lambs were inoculated with BRSV and lung DCs 
isolated after infection. Interestingly, BRSV was found to replicate within lung DCs and 
AMs, inducing a mixture of inflammatory and immunomodulatory cytokine mRNA 
transcripts. Of note was a 10 to 15-fold increase in IL-4 transcribed in both lung DCs and 
AMs. BRSV induced a high expression level of CD 14 on lung DCs during first few days of 
infection. Overall, lung DCs can be infected by BRSV and surface antigen expression and 
tracer uptake abilities were initially decreased compared to DCs from control lambs. Thirdly, 
quantitative differences in cytokine gene expression were seen between AMs infected with 
BRSV in vitro and AMs isolated from BRSV infected lambs. Neonatal AMs infected with 
BRSV in vitro produced different amounts of inflammatory cytokines and chemokines when 
compared to TLR3, TLR4, or inactivated BRSV stimulation. In general, these studies 
demonstrate that BRSV infects both neonatal lung DCs and AMs in vivo, inducing a mixed 
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cytokine and chemokine response. The virus has an effect on neonatal AM cytokine 
production in vitro and induces lower levels of gene transcription than known TLR3 and 
TLR4 agonists. Taken together, these studies provide information on the effects of BRSV 
infection in neonatal lamb APCs. 
Specifc Aim 1. These studies determined the phenotypic and functional characteristics of 
isolated ovine neonatal and adult lung DCs. Neonates generate nonprotective immune 
responses to specific respiratory pathogens resulting in increased morbidity and mortality 
when compared to adults. The similarities described here in between neonate and adult lung 
DCs suggest the immaturity of the neonatal lung DC's cannot be the reason for the 
ineffective immune response. 
Healthy neonatal lambs and adult sheep were utilized for the experiments in which 
isolated lung DCs were compared to MDDCs. Regardless of age, ovine lung DCs were 
phenotypically similar to their rodent counterparts with comparable low expression of CD 14, 
CD80/86 and MHC class II (2). Mature MDDCs expressed high MHC class I and CD80/86 
when compared to immature MDDCs from both ages. Functionally, lung DCs took up less 
FITC-OVA than MDDCs regardless the age. Fully mature DCs cannot take up antigen and 
express high levels of CD80, CD86, MHC class II and MHC class I, therefore ovine lung 
DCs exhibit a semi-mature state. The lung tissue derived DCs were able to stimulate 
allogeneic T cell responses which is similar to reported data using rodent and human lung 
DCs in allogeneic and antigen specific T cell proliferation (2, 3, 5). Overall, lung DCs from 
neonatal lambs and adult sheep were similar in phenotype and function. 
Specifc Aim 2. This set of experiments determined that BRSV actively replicates within lung 
DCs in vivo. Interestingly when observing lung DCs, viral infection does not induce high 
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surface antigen expression (CD80/86, MHC class I) necessary to mount an antiviral response 
until five days after infection. These lung DCs are able to endocytose antigen and 
functionally are not inhibited by the virus. Though BRSV does not inhibit lung DC 
phenotype or antigen uptake functions, the virus does modulate cytokine mRNA 
transcription. Most importantly, high levels of IL-4 and IL-10 mRNA transcripts were 
produced after BRSV infection. Production of these immunomodulatory cytokines is 
supported by in vitro data of RSV infected MDDCs and nasal washes from infected children 
reporting similar IL-4 and IL-10 being produced (6, 8, 12). Overall, in vivo BRSV infection 
of lung APCs leads to skewing of their cytokine responses towards a type II cytokine 
environment. 
Specifc Aim 3. Data obtained from these studies demonstrated that neonatal and adult AMs 
can support active BRSV replication in vivo and in vitro, and the viral cytokine responses 
induced are quantitatively different from other stimuli. First, in vivo data from neonatal AMs 
demonstrated that infection with either BRSV or human RSV resulted in production of IL-4 
and IL-10 mRNA transcripts. Secondly, utilizing in vitro infection of neonatal AMs 
demonstrated that viral replication was not necessary for induction of gene transcription. 
Quantitatively, higher fold increases in mRNA transcripts were induced in AMs isolated after 
in vivo BRSV infection compared to in vitro BRSV infection. These results point to the fact 
that there are important quantitative differences in the levels of cytokine mRNA transcripts 
induced in AMs from BRSV infected lambs compared to the levels of transcripts induced in 
AMs infected with BRSV in vitro. 
Taken together, the reported dissertation studies here in support that in vivo infection 
of BRSV modulates lung APCs by inducing both IL-4 and IL-10 gene transcription. These 
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data are supported by several studies examining children infected with RSV (1,4, 10). 
Accumulating evidence suggests that the Th2 cytokine response and CD4+ T cells induced 
after RSV infection are responsible for the immunopathogenesis seen in children. Though the 
in vivo source of the cytokines was unknown, the production of IL-4 and IL-10 in severe 
RSV infection has been suggested to predispose children to recurrent wheezing, asthma or 
other chronic pulmonary conditions later in childhood (11). This dissertation has 
demonstrated that two sources of the in vivo IL-4 and IL-10 induced after RSV infection are 
lung DCs and AMs. 
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